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INTRODUCTION 
 
                 Herbal medicine is the use of appropriate plants or plant parts for their 
therapeutic and medicinal value. It is the oldest form of health care known to 
humanity that has been used by all cultures throughout the world. Herbal medicines as 
the major remedy in traditional system of medicine have been used in medicinal 
practice since antiquity. The practices continue today because of its biomedical 
benefits as well as place in cultural belief in many parts of world and have a great 
contribution towards maintaining human health.  
WHO has defined herbal medicines as finished labeled medicinal product that 
contain active ingredients, aerial or underground parts of the plant or other plant 
material or combinations. 
India has one of the richest plants medical traditions in the world. Around 
20,000 medicinal plant species have been recorded recently. There are estimated to be 
around 25,000 effective plant based formulations, used in folk medicine and known to 
rural communities in India. There are over 1.5 million practitioners of traditional 
medicinal system using medicinal plants in preventive, promotional and curative 
application. It is estimated that there are over 7800 medicinal drug manufacturing 
units in India, which consume about 2000 tonnes of herbs annually. 
During 1950-1970 approximately 100 plant based new drugs were introduced 
in the USA drug market including Deserpidine, Reseinnamine, Reserpine, Vinblastine 
and Vincristine, which are derived from higher plants. From 1971 to 1990 new drugs 
such as Ectoposide, Eguggulsterone, Teniposide, Nabilone, Plaunotol, 
Zguggulsterone, Lectinan, Artemisinin  and Ginkolides appeared all over the world. 
2% of drugs were introduced from 1991 to 1995 including Paciltaxel, Toptecam, 
Gomistin and Irinotecamect. Plant based drugs provide outstanding contribution to 
modern therapeutics, for example; Serpentine isolated from the root of Indian plant 
Rouwolfia serpentine in 1953, was a revolutionary event in the treatment of 
hypertension. Vinblastine isolated from the Catharanthus rosesus is used for the 
treatment of Hodgkins, Choriocarcinoma, non-hodgkins lymphomas, Leukemia in 
children, testicular and neck cancer. Vincristine is recommended for acute 
lymphocytic leukemia in childhood advanced stages of hodgkins, lymphosarcoma, 
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cervical and breast cancer. Podophyllotoxin is a constituent of Phodophyllum emodi 
currently used against testicular, small cell lung cancer and lymphomas. More than 64 
plants have been found to possess significant antibacterial properties and more than 
24 plants have been found to possess anti-diabetic properties. Daboia russelli and 
Naja kaouthia used as antidote activity. Recently, an active compound from 
Strychnous nuxvomica seed extract, inhibited viper venom induced lipid peroxidation 
in experimental animals. 
Medicinal herbs as potential source of therapeutics has attained a significant 
role in health system all over the world for both humans and animals not only in the 
diseased condition but also as potential material for maintaining proper health. Herbal 
medicines are currently in demand and their popularity is increasing day by day. 
(Sheetal varma & singh, 2008) 
 
In conventional medicine, the liver is known to play a central role in the 
maintenance of metabolic homeostasis by its involvement in carbohydrate, lipid and 
protein metabolism. It converts sugar into glycogen, carbohydrates and proteins into 
fats, toxic ammonia into nontoxic urea, etc. It produces bile, blood coagulating and 
anti-coagulating factors, proteins, and enzymes. It stores critical trace elements and 
vitamins and is responsible for detoxification and elimination of various toxins, 
carcinogens, nitrogen-containing waste products, and alcohol. The maintenance of a 
healthy liver is vital to overall health and well-being. Unfortunately, environmental 
toxins, poor eating habits, alcohol consumption, and therapeutic drug use often abuse 
this vital organ, and as a consequence there is an overall decline in metabolic 
functions of the liver. This hepatotoxicity eventually leads to serious diseases like 
hepatitis, cirrhosis, alcoholic liver disease, and ultimately results in hepatic cancers 
(liver tumors). 
 
 
Hepatic diseases like acute or chronic hepatitis and cirrhosis are some of the 
major causes of significant human mortality, which may result from a wide variety of 
viral infections and a range of toxins including alcohol. (Lakshmi Chandra mishra, 
2004) 
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A large number of plants and formulations have been claimed to have 
hepatoprotective activity. Nearly 160 phytoconstituents from 101 plants have been 
claimed to possess liver protecting activity. In India, more than 87 plants are used in 
33 patented and proprietary multi ingredient plant formulations. In spite of the 
tremendous advances made, no significant and safe hepatoprotective agents are 
available in modern therapeutics. Therefore, due importance has been given globally 
to develop plant-based hepatoprotective drugs effective against a variety of liver 
disorders. (Mohamed saleem et al., 2010) 
 
Plants with hepatoprotective activity 
 
Botanical name Family Parts Used  
Areca catechu Linn  Arecaceae  Inflorescence  
Arenga wightii Griff  Arecaceae  
Inflorescence and fruit 
husk  
 
Aristolochia indica Linn  Aristolochiaceae  Roots (tender)   
Asparagus racemosus Willd  Liliaceae  Roots   
Azadirachta indica A. Juss  Meliaceae  Root Bark   
Centella asiatica Urban  Apiaceae  Whole Plant   
Ceratopteris siliquosa (L) 
Copel  
Ceratoptendaceae  Whole Plant  
 
Cuminum cyminum Linn  Apiaceae  Fruit   
Curcuma domestica Val  Zingiberaceae  Fresh rhizome   
Desmodium biflorum Linn  Fabaceae  Whole plant   
Elettaria cardamomum 
Maton  
Zingiberaceae  Seed  
 
Ficus glomerata Roxb  Moraceae  Fruit   
Ficus racemosa Linn  Moraceae  Tender root   
Hibiscus lampas Cav.  Malvaceae  Fresh root   
Ixora coccinea Linn  Rubiaceae  Fresh root   
Impatiens henslowiana Arn  Balsaminaceae  Flowers and leaves   
Momordica subangulata Bl.  Cucurbitaceae  Fruits (tenders)   
Moringa oleifera Lam  Moringaceae  Stem bark   
Naregamia alata W & A  Meliaceae  Whole plant   
Phyllanthus fratenus Webst.  Euphorbiaceae  Whole plant   
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Piper longum Linn Piperaceae Stem 
Ricinus communis Linn  Euphorbiaceae  Tender Leaves  
Allium cepa  Alliaceae  Bulbs  
Allium sativum  Alliaceae  Bulbs  
Aphanamixis polystachya  Meliaceae  
Stem, Root bark, 
Seeds  
Apium graveolens  Apiaceae  Seeds  
Arbutus unedo  Ericaceae  Leaves, Stem Bark.  
Argemone mexicana  Papaveraceae   
Aspargus officinalis  Liliaceae  Root  
Azadirachta indica  Meliaceae  Leaves  
Boerhaavia diffusa  Nyctaginaceae  
Whole plant with 
root  
Calotropis gigantean  Asclepiadaceae  Leaves  
Carica papaya
*** 
Caricaceae   
Centella asiatica  Apiaceae  
Whole plant with 
root  
Cichorium intybus  Asteraceae  Leaves and root  
Cynara scolymus  Asteraceae  Leaves and root  
Daucus carota  Apiaceae  Fruit and root  
Eclipta prostrata  Asteraceae  Whole plant  
Foeniculum vulgare  Apiaceae  Seeds  
Fumaria officinalis  Fumiriaceae  Whole plant  
Glycosmis pentaphylla  Rutaceae   
Iris germanica  Iridaceae  Rhizome  
Fumaria parviflora  Fumaricaceae  Whole plant  
Lobelia inflata  Lobeliaceae  Whole plant  
Lycopodium clavatum  Lycopodiaceae  Plant and spores  
Moringa pterygosperma  Moringaceae  
Leaves, stem, root  
and gum  
Myristica fragrans  Myristicaceae  Fruit  
Myrtus communis  Myrtaceae  Leaves  
Phyllanthus emblica  Euphorbiaceae  Root  
Primula obconica  Primulaceae   
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Raphanus sativus  Brassicaceae  Whole plant    
Ruscus aculeatus  Ruscaceae  
Whole plant with 
root  
 
Santolina chamaecyparissus  Asteraceae  Whole plant   
Sarothamnus scoparius  Papilionaceae  Root   
Silibum marianum  Asteraceae  Seeds   
Solanum nigrum  Solanaceae  Leaves   
Taraxacum officinale  Asteraceae  Root   
Terminalia chebula  Combretaceae    
Tinospora cordifolia  Menispermaceae  Fresh stem   
Trigonella foenum graecum  Papilionaceae  Leaves and seeds   
Viola odorata  Violaceae  Whole plant   
Zingiber officinale  Zingiberaceae  Rhizome.   
  
( Dr. Nanjaian mahadevan, 2007) 
1.1 PHYSIOLOGY OF LIVER  
The liver is the one of the largest, most important and least appreciated organs 
in the body. The bulk of the liver consist of hepatocytes, which are epithelial cells 
with a uniconfiguration. 
 
The liver is essentially an exocrine gland secreting bile into the intestine. But, 
the liver also functions as an endocrine gland & blood filter.  
 
The liver has a diversity of functions not typically associated with glands. The 
liver is a metabolic factory synthesizing and breaking down a variety of substance it 
functions include all of the following. 
 
i)  Formation and secretion of bile. 
ii) Storage of glycogen, buffer for blood glucose. 
iii) Synthesis of urea. 
iv) Metabolism of cholesterol and fat. 
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v) Synthesis and endocrine secretion of many plasma proteins, including clotting 
factors. 
vi) Detoxification of many drugs and other poisons. 
vii) Cleansing of bacteria from blood. 
viii) Processing of several steroid hormones and vitamin-D. 
ix) Volume reservoir of blood. 
x) Catabolism of HB from worn out red blood cells. (Linda Ferrell, 2001) 
1.2 STRUCTURE 
The lobes of the liver are made up of tiny functional units, called lobules, 
which are just visible to the naked eye. Liver lobules are hexagonal in outline and are 
formed by cubical-shaped cells the hepatocytes arranged in pairs of columns radiating 
from a central vein. Between two pairs of columns of cells containing a mixture of 
blood from the tiny branches of the portal vein and hepatic artery. This arrangement 
allows the arterial blood and portal venous blood (with a high concentration of 
nutrients) to mix and come into close contact with the liver cells. Amongst the cells 
lining the sinusoids are hepatic macrophages (Kupffer cells) whose function is to 
ingest and destroy worn out blood cells and any foreign particles present in the blood 
flowing through the liver. 
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Microanatomy of liver 
 
 
 
 
 
 
 
 
 
Blood drains from the sinusoids into central or centrilobular veins. These then 
join with veins from other lobules, forming larger veins, until eventually they become 
the hepatic veins, which leave the liver and empty in to the inferior vena cava. One of 
the functions of the liver is to secrete bile. It is seen that bile canaliculi run between 
the columns of liver cells. This means that each column of hepatocytes has a blood 
sinusoid on one side and a bile canaliculus on the other. The canaliculi join up to from 
larger bile canals until eventually they form the right and left hepatic ducts, which 
drain bile from the liver. (Anne Waugh and Allison Grant, 2011) 
Lymphoid tissue and a system of lymph vessels are also present in each lobule. 
1.3 HISTOLOGY        
The liver is divided into many hepatic lobules. Inflow to the liver involves 
hepatic arteries, which bring oxygenated blood to hepatic tissue, and portal veins, 
which bring nutrients and other compounds absorbed by the GI tract to be processed 
and/or stored in the liver. Outflow also volves two routes – hepatic veins which drain 
into the inferior vena cava and the common hepatic duct which joins the cystic duct 
and empties bile into the duodenum.  
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Major characteristics of the liver are portal triads (labeled “portal” in bottom 
left and shown in the middle) and central veins (labeled in bottom left and shown in 
the right).  
The portal triad contains 1) the portal vein, 2) the hepatic artery, and 3) the bile 
duct. Each has its typical appearance. The central vein is lined with endothelial cells, 
with perforations into which the sinusoids empty. 
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HISTOLOGY OF NORMAL LIVER 
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The central veins lead to sub lobular veins, which reach collecting veins, 
hepatic veins, and finally the inferior vena cava. The venous outflow of the liver has 
no regard to the organization of the lobules. 
The liver sinusoids are dilated, capillary-like vessels lined by fenestrated, 
discontinuous epithelium (labeled “e”). Interspersed among the endothelial cells are 
Kupffer cells (labeled “k”), which are fixed macrophages within the hepatic tissue. 
They have distinct cytoplasm that may enter the sinusoidal lumen and function like 
other macrophages within the body. They also break down damaged red blood cell 
hemoglobin. (http//www.med.unichedu.com) 
There are many spaces between the hepatocytes and sinusoidal epithelial cells. 
They are referred to the space of Disse where exchange between hepatocytes and 
blood flow takes place. 
 
1.4 HEPATIC DISEASE  
Hepatic  disease  (Liver  disease)  is  a  term  for  a collection of conditions, 
diseases, and  infections  that affect the cells, tissues, structures, or functions of the 
liver  and  can  be  defined  as  an  alanine amino tranferase  (ALT)/ SGPT  level  of  
more  than three  times  the  upper  limit  of  the  normal  range,  an alkaline 
phosphatase (ALP) level of more than twice the  upper limit  of  normal,  or  a  total  
bilirubin  level (TBL) of more than twice the upper limit of normal if associated  with  
any  elevation  of  the  alanine amino transferase or alkaline phosphatase level. 
 Liver  has  a  wide  range  of  functions,  including detoxification,  protein  
synthesis,  production  of  biochemical necessary  for digestion and synthesis 
as well as breakdown of small and complex molecules, many  of  which  are  
necessary  for  normal  vital function. 
  A hepatic injury can disturb all these functions of liver. Liver disease and 
infections are caused by a various conditions  including  viral  infections,  
bacterial invasion,  malnutrition,  alcoholism  and  chemical  or physical  
changes  within  the  body.  There  are  many disease  and  condition  which  
are  responsible  for hepatic disease or hepatic injury like 
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 Hepatotoxicity 
Tendency  of  an  agent,  usually  a  drug  or  alcohol,  to have  a  destructive  
effect  on  the  liver. 
 Hepatic necrosis 
Death of liver cells. 
 Hepatic steatosis 
Too much fat in the liver; may be associated with a life-threatening condition 
called lactic acidosis. 
 Alcoholic cirrhosis  
A condition of irreversible liver disease due to the chronic inflammatory and 
toxic effects of ethanol on the liver. 
 Hepatitis 
Inflammation  of  the liver  due  to  viral  infection,  larger  intake  of  alcohol, 
drug  adverse  drug  reaction  and  toxicity, toxic  agent obtained  from  drugs,  
chemical  agent  and  viruses. 
 Jaundice 
A morbid condition, characterized by yellowness of the eyes, skin, and urine, 
whiteness of the  feces, constipation, queasiness, loss of  appetite, and general  
languor and  lassitude.   
 Fatty Liver 
Disorders associated with fat metabolism and many other conditions. (Shakthi 
Dwivedi et al., 2011) 
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1.5 HEPATOTOXICITY 
Liver plays a central role in transforming and clearing chemicals and is 
consequently susceptible to the toxicity induced from hepatic agents. Chemicals  that  
cause  liver  injury  are  termed hepatotoxins,  and more  than  900 drugs  have been 
implicated in causing liver injury and it is the most common  reason  for a drug to be 
withdrawn  from the market.  Chemicals often cause subclinical injury to liver which 
may be manifest by abnormal liver enzyme tests. Certain medicinal agents when 
taken in overdoses and sometimes even when introduced within therapeutic ranges 
may injure the organ. Other chemical agents such as those used in laboratories and   
industries, natural chemicals (e.g. microcystins) and herbal remedies can also induce 
hepatotoxicity.  
The unique property of liver to metabolize substances and its close 
relationship with the gastrointestinal tract, it is highly susceptible to injury from drugs 
and other substances. Approximately 75%  of  blood  reaching  the liver arrives  
directly  from  gastrointestinal  organs  and then spleen through portal veins which 
bring drugs and  xenobiotics  in  concentrated  form.  Numerous mechanisms  may  be  
cited  to  be  responsible  for either  inducing  hepatic  injury  or  worsening  the 
damage process. Although the exact mechanism of hepatic injury remains largely 
unknown, it appears to involve 2 pathways-direct hepatotoxicity and adverse immune 
reactions. In most  instances, hepatic injury is initiated by the  bioactivation  of drugs  
to  chemically  reactive  metabolites,  which have  the  ability  to  interact  with  
cellular macromolecules  such  as  proteins,  lipids,  and nucleic acids,  leading  to  
protein dysfunction,  lipid peroxidation, DNA damage, and oxidative stress. 
Additionally,  these  reactive  metabolites may  induce  disruption  of  ionic  gradients  
and intracellular  calcium  stores,  resulting  in mitochondrial  dysfunction  and  loss  
of  energy production.  
 Its  dysfunction  releases  excessive amount  of  oxidants  which  in  turn  
injures  hepatic cells.  Activation  of  some  enzymes  in  the Cytochrome P-450  
system  such  as  CYP2E1  also leads  to  oxidative  stress. Injury to hepatocytes and 
bile duct cells lead to accumulation of bile acid inside liver. This promotes further 
liver damage.  This impairment of cellular function can culminate in cell death and 
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possible liver failure. Hepatic  cellular  dysfunction  and  death  also  have the  ability  
to  initiate  immunological  reactions, including  both  innate  and  adaptive  immune 
responses. Stress and damage to hepatocytes result in the release of signals that 
stimulate activation of other cells, particularly those of the innate immune system, 
including Kupffer cells (KC), Natural killer (NK) cells, and NKT cells. These cells 
contribute to the progression of liver injury by producing pro inflammatory mediators 
and secreting chemokines to further recruit inflammatory cells to the liver.  
It  has  been  demonstrated  that  various inflammatory  cytokines, such as 
tumor necrosis factor  (TNF)-α, interferon  (IFN)-γ, and  interleukin (IL)-1β, produced  
during  hepatic  injury  are involved  in  promoting  tissue  damage. However,  innate  
immune  cells  are  also  the  main source  of  IL-10,  IL-6,  and  certain  
prostaglandins, all  of  which  have  been  shown  to  play a hepatoprotective role. 
Thus, it is the delicate balance of inflammatory and hepatoprotective  mediators  
produced  after activation  of  the  innate  immune  system  that determines  an  
individual’s  susceptibility  and adaptation to hepatic injury. (Varsha kashaw et al., 
2011) 
 
1.6 MECHANISM OF HEPATOTOXICITY CAUSED BY DIFFERENT 
AGENTS 
Damage  to  the  liver  is  not  due  to  the  drug  itself  but  due to a  toxic 
metabolite N-acetyl-p benzo quinonimine ( NAPQI or NABQI) which is produced by 
cytochrome P 450 enzymes in the liver. 
In overdoses large amount of NAPQI is generated which overwhelm the 
detoxification process and lead to damage to liver cells. Nitric acid also plays role in 
inducing toxicity. The mechanism of hepatotoxicity caused by NSAIDs were 
documented to be both idiosyncratic and dose dependant. Aspirin and phenylbutazone 
are associated with intrinsic hepatotoxicity; idiosyncratic reaction has been associated 
with ibuprofen, sulindac, phenylbutazone, piroxicam, diclofenac and indomethacin. 
Enlarged liver is a rare side effect of long term steroid use in children. 
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 Carbon tetrachloride  
Liver injury due to carbon tetrachloride in rats was first reported in1936 and 
has been widely and successfully used by many investigators. Carbon tetrachloride  is  
metabolized  by  cytochrome  P 450  in  endoplasmic  reticulum and mitochondria 
with  the  formation of CCl3 O  , a  reactive oxidative  free  radical, which  initiates 
lipid peroxidation. 
                                  CCl4                                        CClO3- + O  
Administration of a single dose of CCl4 to a rat produces, within 24 hrs,          
a centrilobular necrosis and fatty changes. The poison reaches its maximum 
concentration in the liver within 3 hrs of administration. Thereafter, the level falls and 
by 24 hrs there is no CCl4 left in the liver. The development of necrosis is associated 
with leakage of hepatic enzymes into serum.  
 Dose of CCl4: 0.1 to 3 ml/kg I.P.  
 Galactosamine 
Galactosamine produces diffuse type of liver injury simulating viral hepatitis. 
It presumably disrupts the synthesis of essential uridylate nucleotides resulting in 
organelle injury and ultimately cell death. Depletion of those nucleotides would 
impede the normal synthesis of RNA and consequently would produce a decline in 
protein synthesis. This mechanism of toxicity brings about an increase in cell 
membrane permeability leading to enzyme leakage and eventually cell death. The 
cholestasis caused by galactosamine may be from its damaging effects on bile ducts 
or ductless or canalicular membrane of hepatocytes. Galactosamine decrease the bile 
flow and its content i.e. bile salts, cholic acid and deoxycholic acid. Galactosamine 
reduces the number of viable hepatocytes as well as rate of oxygen consumption.  
Dose of D-Galactosamine: 400 mg/kg, I.P.  
 Thioacetamide 
Thioacetamide interferes with the movement of RNA from the nucleus to 
cytoplasm which may cause membrane injury. A metabolite of thioacetamide 
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(perhaps s-oxide) is responsible for hepatic injury. Thioacetamide reduce the number 
of viable hepatocytes as well as rate of oxygen consumption.  It  also decreases  the  
volume  of  bile  and  its  content  i.e. bile  salts, cholic acid and deoxycholic acid.  
 Dose of Thioacetamide: 100 mg/kg, S.C.  
 Alcohol                                                                                                                                                                 
The effects of ethanol have been suggested to be a result of the enhanced 
generation of oxyfree radicals during its oxidation in liver. The peroxidation of 
membrane lipids results in loss of membrane structure and integrity. This results in 
elevated levels of ¡-glutamyl transpeptidase, a membrane bound enzyme in serum. 
Ethanol inhibits glutathione peroxidase, decrease the activity of catalase, superoxide 
dismutase, along with increase in levels of glutathione in liver. The decrease in 
activity of antioxidant enzymes superoxide dismutase, glutathione peroxidase are 
speculated  to  be due to the damaging effects of free radicals  produced  following 
ethanol exposure or alternatively could be due to a direct effect of  acetaldehyde, 
formed by oxidation of ethanol. Alcohol pre-treatment stimulates the toxicity of CCl4 
due to increased production of toxic reactive metabolites of CCl4, namely trichloro-
methyl radical by the microsomal mixed function oxidative system. This activated 
radical binds covalently to the macromolecules and induces peroxidative degradation 
of membrane lipids of endoplasmic reticulum rich in polyunsaturated fatty acids. This 
lipid peroxidative degradation of biomembranes is the principle cause of hepatotoxity.  
 Paracetamol 
Paracetamol, a widely used analgesic and antipyretic drug, produces acute 
liver damage in high doses. paracetamol administration causes necrosis of  the 
centrilobular hepatocytes characterized by nuclear pyknosis and  eosinophilic  
cytoplasm  followed  by large  excessive  hepatic lesion. The covalent binding of  N-
acetyl-P-benzoquinonimine, an oxidative product  of  paracetamol to sulphydryl  
groups  of  protein,  result  in  lipid peroxidative  degradation  of  glutathione level 
and thereby, produces cell necrosis in the liver.   
Dose of Paracetamol: 1 gm/kg P.O.  
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 Antitubercular drugs 
Though  INH,  Rifampicin  and  Pyrazinamide  each  are  potentially  
hepatotoxic,  when  given  in combination,  their  toxic  effect  is  enhanced.  INH is 
metabolized to monoacetyl hydrazine, which is further metabolized to a toxic product 
by cytochrome P450 leading to hepatotoxicity. Patients on concurrent rifampicin 
therapy have an increased incidence of hepatitis. This has been postulated due to 
rifampicin-induced cytochrome P 450 enzyme-induction, causing an increased 
production of the toxic metabolites from acetyl hydrazine (AcHz). Rifampicin also 
increases the metabolism of INH to isonicotinic acid and hydrazine, both of which are 
hepatotoxic. The plasma half life of AcHz (metabolite of INH) is shortened by 
rifampicin and AcHz is  quickly  converted  to  its  active metabolites  by  increasing  
the  oxidative  elimination  rate of AcHz, which  is related to the higher incidence of 
liver  necrosis caused by INH and rifampicin in combination. Rifampicin induces 
hydrolysis pathway of INH metabolism into the hepatotoxic metabolite hydrazine. 
Pharmacokinetic interactions exist between  rifampicin  and  pyrazinamide  in 
tuberculosis patients, when  these drug  are administered concomitantl.  Pyrazinamide 
decrease the blood level of rifampicin by decreasing its bioavailability and increasing 
its clearance. Pyrazinamide, in combination with INH and rifampicin, appears to be 
associated with an increased incidence of hepatotoxicity. (Srinath. Ambarti et al., 
2010) 
Drugs causing liver damage 
Drug Reaction 
Paracetamol 
Acute, direct hepatocellular toxicity; 
chronic toxicity 
Allopurinol Miscellaneous acute reactions 
Amanita mushrooms Acute, direct hepatocellular toxicity 
Aminosalicylic acid Miscellaneous acute reactions 
Amiodarone Chronic toxicity 
Antibiotics Miscellaneous acute reactions 
Antineoplastics Miscellaneous acute reactions 
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Arsenic compounds Chronic toxicity 
Aspirin Miscellaneous acute reactions 
C-17 alkylated steroids Acute cholestasis, steroid type 
Chlorpropamide Acute cholestasis, phenothiazine type 
Diclofenac Acute, idiosyncratic hepatocellular toxicity 
Erythromycin estolate Acute cholestasis, phenothiazine type 
Halothane-related anesthetics Acute, idiosyncratic hepatocellular toxicity 
Hepatic intra-arterial antineoplastics Chronic toxicity 
HMG-CoA reductase inhibitors Miscellaneous acute reactions 
Hydrocarbons Acute, direct hepatocellular toxicity 
Indomethacin Acute, idiosyncratic hepatocellular toxicity 
Iron Acute, direct hepatocellular toxicity 
Isoniazid 
Acute, idiosyncratic hepatocellular toxicity; 
chronic toxicity 
Methotrexate Chronic toxicity 
Methyldopa 
Acute, idiosyncratic hepatocellular toxicity; 
chronic toxicity 
Methyltestosterone Acute cholestasis, steroid type 
Monoamine oxidase inhibitors Acute, idiosyncratic hepatocellular toxicity 
Niacin Chronic toxicity 
Nitrofurantoin Chronic toxicity 
Oral contraceptives Acute cholestasis, steroid type 
Phenothiazines                                       
(eg,chlorpromazine) 
Acute cholestasis, phenothiazine type; 
chronic toxicity 
Phenylbutazone Acute cholestasis, phenothiazine type 
Phenytoin Acute, idiosyncratic hepatocellular toxicity 
Phosphorus Acute, direct hepatocellular toxicity 
Propylthiouracil Acute, idiosyncratic hepatocellular toxicity 
Quinidine Miscellaneous acute reactions 
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Sulfonamides Miscellaneous acute reactions 
Tetracycline, high-dose Acute, direct hepatocellular toxicity 
Tricyclic antidepressants Acute cholestasis, phenothiazine type 
Valproate Miscellaneous acute reactions 
Vitamin A Chronic toxicity 
 
  
 
1.7 ACETAMINOPHEN / PARACETAMOL INDUCED HEPATOTOXICITY 
 
Over doses of the analgesic and antipyretic acetaminophen represents one of 
the most common pharmaceutical poisoning. Although considered safe at therapeutic 
doses, in over dose, acetaminophen produces a centrilobular hepatic necrosis that can 
be fatal. 
 
1.8 ACETAMINOPHEN METABOLISM 
 
There are 3 pathways for acetaminophen metabolism 
 
Conjugation with sulfate, conjugation with glucuronide, or metabolism by the 
cytochrome P-450 oxidase enzyme system. The first two processes account for the 
metabolism of approximately 90% of an ingested dose. The third process accounts for 
the metabolism of approximately 5% of an ingested dose and is the pathway of 
concern in overdose. 
 
Metabolism by the cytochrome P-450 system produces a metabolite, N-acetyl-
p-benzo quinonimine (NAPQI) that is directly toxic to the liver. When acetaminophen 
is taken in therapeutic doses, this potentially dangerous metabolite is rendered 
harmless by reduced glutathione, an antioxidant compound in the liver. The N-acetyl 
para benzo quinonimine reduced glutathione compound is then excreted by the 
kidneys. However, when acetaminophen is taken in excess, the sulfation and 
glucuronidation pathways become saturated. The amount and rate of formation of N-
acetyl para benzo quinonimine are greatly increased, depleting the body’s reduced 
glutathione stores and outstripping its capability to make new reduced glutathione.  
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N-acetyl para benzo quinonimine then covalently binds to hepatocytes and 
causes cell death and subsequent liver dysfunction, which is reflected by changes in 
liver function tests (LFTs) 
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The toxic dose of acetaminophen is > 7.5g or >150mg/kg. Chronic ingestions 
in excess of 4g/day may also be toxic. Certain populations are theoretically at greater 
risk for acetaminophen poisoning: Patients who are malnourished, patients who abuse 
alcohol, patients who smoke, and patients who are taking anti-tubercular or 
antiepileptic drugs. The patient assessment will include the presence or absence of 
these risk factors. (Dana Bartlett, 2004)  
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1.9 RESEARCH ON OXIDATIVE STRESS 
 
Oxidative stress is another mechanism of action that has been postulated to be 
important in the development of acetaminophen toxicity. Thus increased formation of 
superoxide would leads to hydrogen peroxide and peroxidation reactions by phenton 
type of reactions. It has been shown that N-acetyl para benzo Quinonimine very 
rapidly react with GSH. 
 
Under conditions of N-acetyl para benzo Quinonimine formation following 
toxic acetaminophen doses GSH concentrations may be very low in the centri lobular 
cells and the major peroxide detoxification enzymes GSH peroxidase which functions 
very in efficiently under conditions of GSH depletions is expected to be inhibited. 
 
In addition during formation of N-acetyl para benzo Quinonimine by 
Cytochrome P450, the superoxide anion is formed with dismutation leads to hydrogen 
peroxide (H2O2) formation. 
(Grypioti, 2006) 
 
1.10  SCREENING MODELS 
 
 In vivo models  
 
A toxic dose or repeated doses of a known hepatotoxin (carbon tetrachloride 
(CCl4), paracetamol, thioacetamide, alcohol, D-galactosamine, allylalcohol etc.) 
might be administered, to induce liver damage in experimental animals. The test 
substance is administered along with, prior to and/or after the toxin treatment. Liver 
damage and recovery from damage are assessed by quantifying serum marker 
enzymes, bilirubin, bile flow, histopathological changes and biochemical changes in 
liver. An augmented level of liver marker enzymes such as glutamate pyruvate 
transaminase (GPT), glutamate oxaloacetate  transaminase (GOT) and alkaline 
phosphatase in the serum indicates liver damage. Additionally,  hepatotoxicity  may  
result in  decline  of  prothrombin  synthesis  giving  an extended  prothrombin  time  
and  reduction  in clearance  of  certain  substances  such  as bromsulphthalein may be 
used in the assessment of hepatoprotective action of plants. Therapeutic efficacy of a 
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drug against diverse hepatotoxins differs especially when their mechanism of action 
vary. Consequently, the efficacy of each drug has to be tested against hepatotoxins 
which act by varied methods. Hepatotoxic chemicals like CCl4, paracetamol reduces 
the level of metabolizing enzymes in liver. For the above reason, metabolism of 
hexabarbitone is reduced resulting in prolongation of hexa-barbitone induced sleeping 
time. Hence, reduction in CCl4-induced prolongation of hexobarbitone stimulated 
sleeping time may be exploited to screen anti-CCl4 toxicity of drugs in animals. Care 
has to be taken to see that the drug has no direct effect on drug metabolizing enzymes 
or necrosis. 
 
 In vitro studies  
Fresh hepatocyte preparations and primary cultured hepatocytes may be 
exploited to study the anti-hepatotoxic activity of drugs. Hepatocytes are treated with 
hepatotoxin and the effect of the plant drug on the same is evaluated. The activities of 
the transaminases released into the medium are determined.  An augmented activity of 
marker transaminases in the medium indicates liver damage. Parameters such as 
hepatocytes multiplication, morphology, macromolecular synthesis and oxygen 
consumption are determined. Effective  antiviral  assays  using  cell  culture  and 
Polymerase  Chain  Reaction  techniques  remain  to be explored and these may  
emerge  as  a  very promising  strategy  for  in vitro examination  of hepatoprotective 
effect of herbal products. (Varsha kashaw et al., 2011) 
1.11 LIVER FUNCTION TESTS 
 
As the liver performs its various functions it makes chemicals that pass into the 
bloodstream and bile. Various liver disorders alter the blood level of these chemicals. 
Some of these chemicals can be measured in a blood sample. Some tests that are 
commonly done on a blood sample are called liver function tests (LFTs). These 
usually measure the following: 
 
 Alanine transaminase (ALT): This is an enzyme that helps to process proteins. 
(An enzyme is a protein that helps to speed up chemical reactions. Various 
enzymes occur in the cells in the body.) Large amounts of ALT occur in liver 
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cells. When the liver is injured or inflamed (as in hepatitis), the blood level of 
ALT usually rises. 
 
 Aspartate aminotransferase (AST): This is another enzyme usually found inside 
liver cells. When a blood test detects high levels of this enzyme in the blood it 
usually means the liver is injured in some way. However AST can also be released 
if heart or skeletal muscle is damaged. For this reason ALT is usually considered 
to be more specifically related to liver problems. 
 
 Alkaline phosphatase (ALP): This enzyme occurs mainly in liver cells next to 
bile ducts, and in bone. The blood level is raised in some types of liver and bone 
disease. 
 
 Albumin: This is the main protein made by the liver, and it circulates in the 
bloodstream. The ability to make albumin (and other proteins) is affected in some 
types of liver disorder. A low level of blood albumin occurs in some liver 
disorders. 
 
 Total protein: This measures albumin and all other proteins in blood. 
 
 Bilirubin: This chemical gives bile its yellow/green colour. A high level of 
bilirubin in blood will make jaundiced ('yellow'). Bilirubin is made from 
haemoglobin. Haemoglobin is a chemical in red blood cells that is released when 
the red blood cells break down. Liver cells take in bilirubin and attach sugar 
molecules to it. This is then called 'conjugated' bilirubin which is passed into the 
bile ducts.  
 
 A raised blood level of 'conjugated' bilirubin occurs in various liver and bile duct 
conditions. It is particularly high if the flow of bile is blocked. For example, by a 
gallstone stuck in the common bile duct, or by a tumour in the pancreas. It can 
also be raised with hepatitis, liver injury, or long-term alcohol abuse. 
 
 A raised level of 'unconjugated' bilirubin occurs when there is excessive 
breakdown of red blood cells. For example, in haemolytic anaemia. 
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Role of Liver function tests  
 
 To diagnose liver disorders. 
 To monitor the activity and severity of liver disorders. 
 As a routine precaution after starting certain medicines to check that they are 
not causing liver damage as a side-effect. (http//www.patient.co.uk) 
 
1.12 SYNTHETIC HEPATOPROTECTIVE DRUGS  
There are no specific allopathic medicines used as hepatoprotective, although 
different research works are going on. Some drug  like  that  Rimonabant chemically 
described as N-peperidino-5(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-ethylpyrazole-
3-carboxamide, is selective endocannabinoid  (CB1)  receptor  antagonist,  inhibits the 
pharmacological effects of cannabinoids agonists in vitro and vivo and has 
hepatoprotective activity against  hepatotoxicant  like  ethanol.  It has seen that 
administration of rimonabant at 2.5mg/kg, 5mg/kg and 10mg/kg dose level attenuated 
the increased level of the serum enzymes, produced by Ethanol and caused a  
subsequent  recovery  towards normalization almost like that of Silymarin treatment. 
Steroids like corticosteroids are under the study for their hepatoprotective action. 
Many other therapeutic interventions have been studied in alcoholic hepatitis, but  
have  not  been  able  to  show convincing benefit, including trials of anti-oxidants 
(vitamin E, and combination  anti-oxidants),  anti-fibrotics (colchicine),  anti-thyroid  
drugs, promoters of hepatic regeneration (insulin and glucagon), anabolic steroids  
(oxandrolone and testosterone), as well as calcium channel blockers (amlodipine), 
polyunsaturated  lecithin, and a number of complementary and alternative medicines. 
A number of  other  agents  have  been  tested  in  patients including  
propylthiouracil  to decrease the  hyper-metabolic state induced by alcohol. Herbal 
drugs are more widely used than allopathic drugs as hepatoprotectives because they 
are inexpensive, better cultural acceptability, better compatibility with the human 
body and minimal side effects.  In other  hand side effects, interactions and  toxicity 
of  synthetic medicines vary wildly  from  mild  to  severe  include insomnia,  
vomiting,  fatigue,  dry  mouth,  diarrhea, constipation, dizziness,  suicidal  thoughts, 
hostility, difficulty  sitting  still,  depression,  mania,  seizures, coma,  anemia,  hair  
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loss,  high blood  sugar, shoplifting,  swelling,  impotency,  panic  attacks, confusion, 
fainting and death. 
Herbal Approach To Treat Hepatic Disease:  In case of hepatic disease treatment 
herbal drugs are widely used than synthetic drugs. There are various drugs reported as 
hepaoprotective including Silybum marianum,  Andrographis paniculata, Swertia 
chirata, Cinchorium intybus, Picrorhija kurroa, Boerhavia diffusa and many others. 
(Akhil Bhardwaj et al., 2011)                                                     
 
1.13 DRUG PROFILE 
 
Acetaminophen 
 
It is a well documented, non prescription, antipyretic, analgesic drug. 
 
Chemistry 
 
Acetaminophen, paracetamol 
 
C8H9NO2 
 
N-Acetyl-P-Aminophenol; 4
’
-hyrdoxy acetanilide; P-acetamidophenol 
 
 
Chemical Structure of Paracetamol 
  
 
 
 
 
 
 
 
Mol.Wt-151.2 
PKa (-OH)-9.5 
Solubility 
NHCOCH3 
OH 
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In alcohol – 1 in 70 
In water    – 1 in 70 
White, odorless, crystalline powder with a bitter taste. (Churchil livingstone) 
 
Silymarin (reference drug) 
 
A mixture of the isomers  Silibinin, Silicrystin and Silidianin.  The active 
principle from the fruit of Silybum marianum (=Carduus marianus) 
(Compositae).The principle components are the  flavonolignans Silibinin, silicrystin 
and silidianin of which Silibinin is the major component. 
Chemical Structure of Silymarin 
 
 
 
 
 
 
Chemical Name : 2,3-Dihydro-3-(4-hydroxy-3-
methoxyphenyl)-2-  
(hydroxymethyl)-6-(3,5,7-trihydroxy-4- 
oxobenzopyran-2-yl) benzodioxin. 
 
Molecular Formula  : C25H22O10 
 
Molecular Weight  : 482.44  
 
Scientific name  : Milk Thistle 
 
 
Other Names: Cardui mariae, Carduus marianum, Holy Thistle, Lady's 
Thistle, Legalon, Marian Thistle, Mariendistel, Mary Thistle, Our Lady's Thistle, 
Silimarina, Silybin, Silybum marianum, St. Mary Thistle.  
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  Hepatoprotective role of silymarin 
 
 Silymarin has shown differing degrees of effectiveness for protecting the 
liver from damage caused by alcohol, chemicals, drugs, diseases, and 
poisonous plants. It is used to treat both acute conditions (such as poisoning) 
and long-term diseases (such as Hepatitis C). Silymarin and other chemicals 
in milk thistle are believed to protect liver cells in several different ways.  
 Silymarin has antioxidant properties/free radical scavenging effect and has 
been used for the treatment of hepatic disorders.  
 Anti-inflammatory effects of Silymarin help in preventing liver cells from 
swelling after being injured. 
 Silymarin seems to encourage the liver to grow new cells, while discouraging 
the formation of inactive fibrous tissue. 
 By changing the outside layer of liver cells, Silymarin actually may keep 
away certain harmful chemicals from getting into liver cells. 
 Milk thistle may also cause the immune system to be more active. (The 
Extra Pharmacopoeia 33
rd
 edition) 
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              2.1 PLANT PROFILE                             
 
Botanical Name(s) : Glycyrrhiza glabra Linn. 
 
Kingdom  : Plantae 
 
 
Division  : Magnoliophyta 
 
Class  : Magnoliopsida 
 
Order  : Violales 
 
Family  : Fabaceae 
Genus  : Glycyrrhiza  
Species  : Glycyrrhiza glabra 
 
Popular Name(s) :           Yashti-madhu, Yashti-madhuka, Mulhathi, Jethi-madh 
 
 
Parts Used  : Leaves, Roots. 
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2.3 NUTRITIONAL VALUE PER 100G (3.5 OZ) 
Energy 163 kj (39 kcal) 
Carbohydrates 9.81 g 
Sugars 5.90 g 
Dietary fibre 1.8 g 
Fat 0.14 g 
Protein 0.61 g 
Vitamin A equiv. 328 μg (36%) 
Thiamine (Vit. B1) 0.04 mg (3%) 
Riboflavin (Vit. B2) 0.05 mg (3%) 
Niacin (Vit. B3) 0.338 mg (2%) 
Vitamin B6 0.1 mg (8%) 
Folate (Vit. B9) 38 μg (10%) 
Vitamin C 61.8 mg (103%) 
Calcium 24 mg (2%) 
Iron 0.10 mg (1%) 
Magnesium 10 mg (3%) 
Phosphorus 5 mg (1%) 
Potassium 257 mg (5%) 
Sodium 3 mg (0%) 
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2.4 ORIGIN, DISTRIBUTION AND MORPHOLOGY 
Liquorice, or licorice, is the root of Glycyrrhiza glabra from which a sweet flavour 
can be extracted. The liquorice plant is a herbaceous perennial legume native to 
southern Europe and parts of Asia, such as India. It is not botanically related to anise, 
star anise, or fennel, which are sources of similar flavouring compounds. 
Most liquorice is used as a flavouring agent for tobacco, particularly US blend 
cigarettes, to which liquorice lends a natural sweetness and a distinctive flavour and 
makes it easier to inhale the smoke by creating bronchodilators, which open up the 
lungs. Liquorice flavours are also used as candies or sweeteners, particularly in some 
European and Middle Eastern countries. Liquorice extracts have a number of medical 
uses, and they are also used in herbal and folk medications. Excessive consumption of 
liquorice (more than 2 mg/kg/day of pure glycyrrhizinic acid, a liquorice component) 
may result in adverse effects, and overconsumption should be suspected clinically in 
patients presenting with otherwise unexplained hypokalemia and muscle weakness  
2.6 COMMON MEDICINAL USES 
Therapeutic constituents: 
The principal constituent of Licorice to which it owes its characteristic sweet taste is 
glycyrrhizin. Other constituents present in Licorice are glucose, sucrose, mannite, 
starch, asparagine, bitter principals, resins, a volatile oil and coloring matter, which 
collectively give Licorice its pharmacological properties. 
Key therapeutic benefits: 
Licorice lowers stomach acid levels, relieves heartburn and indigestion and prevents 
ulcer formation. Through its beneficial action on the liver, it increases bile flow and 
lowers cholesterol levels. In the respiratory system, its soothing and healing action 
reduces irritation and inflammation. Licorice enhances immunity by boosting levels 
of interferon, a key immune system chemical that fights off viruses. 
The phytoestrogens in Licorice have a mild estrogenic effect, making the herb 
potentially useful in easing certain symptoms of premenstrual syndrome (PMS), such 
as irritability, bloating and breast tenderness. 
Its anti-allergic property is useful in allergic rhinitis, conjunctivitis and bronchial 
asthma. 
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When applied topically, Licorice can be used to fight dermatitis, eczema and 
psoriasis. 
SCIENTIFIC REVIEW 
            Halim et al., 2011 evaluated the acute toxicity of Glycyrrhiza glabra Linn. 
leaf extract on Sprague dawley rats. The results showed the single oral dose of 
Glycyrrhiza glabra Linn. leaf extract did not produce mortality or significant changes 
in the body weight, food and water consumption. The weight of the internal organs 
were normal. Hemoglobin, hematocrit, red blood cell and total protein were 
significantly increased due to dehydration. Apart from triglyceride, no significant 
change in biochemical parameters were noted. 
             Doughari et al., 2007 evaluated the antibacterial activity of root extracts of 
Glycyrrhiza glabra Linn. there was no significant activity in aqueous extract. 
Methanol extract showed a significant activity against bacteria. 
          Oyekunle et al., 2010 studied the effect of aqueous extract of Glycyrrhiza 
glabra Linn. leaf on male fertility. The extract showed a significant reduction in mean 
values of sperm count, motility, viability and serum testosterone concentration 
compared with control. Histopathology revealed a marked degeneration of the 
seminiferous tubule epithelium and disruption of interstitial cells of the testis which 
was not visible in control group. 
           Bamidele et al., 2008 investigated the anti-inflammatory activity of ethanolic 
extract of Glycyrrhiza glabra Linn. leaves in rats using carrageenan induced paw 
oedema, cotton pellet granuloma and formaldehyde induced arthritis model. The 
results showed that the extract significantly reduced paw oedema in the carrageenan 
test, reduced granuloma formation and significantly reduced the persistant oedema 
from the 4
th
 day to the 10
th
 day of investigation. 
          Adeneye et al., 2009 investigated the hypoglycemic, hypolipidemic and 
cardioprotective effects of aqueous seed extract of Glycyrrhiza glabra Linn. in normal 
male wistar rats for 30days. The results showed that the extract significantly lowered 
the FBS, TG, TC, LDL-C and VLDL-C dose dependently, with dose-related elevation 
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of HDL-C. Compared to untreated animals. The extract also significantly lowered the 
AI and CAI indices dose dependently. 
          Mahmood et al., 2005 investigated the wound healing property of Glycyrrhiza 
glabra Linn. aqueous leaf extract in rats. The results strongly documented the 
beneficial effect of leaf extract on wound healing process in rats. 
           Ogunyemi et al., 2008 evaluated the antisickling property of Glycyrrhiza 
glabra Linn. fruit pulp using sodium meta bisulphate sickled red blood cells. A 
highest antisickling property of 87% inhibitory and 74% reversal activity was noted 
from 5 day fermentation product. The methanol extract showed 64% inhibitory and 
55% reversal activities while chloroform extract was inactive. 
          Fakeye et al., 2007 investigated the effect of co administration of Glycyrrhiza 
glabra Linn. leaf extract on activity of two oral hypoglycemic agents. The 
Glycyrrhiza glabra Linn. leaf extract showed significant interactions which affected 
the oral hypoglycemic activities of the drugs. The extract delayed the onset of 
hypoglycemic activity of glimepride and increased the hypoglycemic activity of 
metformin. 
         Olagunju et al., 2009 evaluated the nephroprotective activity of aqueous seed 
extract of Glycyrrhiza glabra Linn. in carbon tetrachloride induced renal injury in 
wistar rats. The results showed, the seed extract significantly lowered the biochemical 
parameters (serum uric acid, urea and creatinine levels) in dose related fashion. This 
showed the nephroprotective effect of Glycyrrhiza glabra Linn. on ccl4 renal injured 
rats. 
            Adeneyee et al., 2009 evaluated the effect of aqueous seed extract of 
Glycyrrhiza glabra Linn.  in ccl4 induced hepatotoxicity in rats. A dose-dependent 
significant decrease in serum liver marker enzymes of acute liver injury (ALT, AST), 
serum lipids (TG, TC, HDL-C, and VLDL-C) and serum proteins (TP and ALB). 
Were noted in extract treated group. The results obtained justified the folkloric 
application of CPE in the treatment of drug related hepatic injury. 
         Anaga and Onehi et al., 2010 evaluated the antinociceptive and anti-
inflammatory effect of methanol extract of Glycyrrhiza glabra Linn. seeds in mice 
and rats. The extract significantly reduced the paw licking in early and late phase of 
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formalin-induced nociception. The extract also reduced the number of acetic-acid 
induced abdominal contractions. The anti-inflammatory effect was found to be dose 
dependent. 
          Srikanth et al., 2010 studied the in-vitro antioxidant activity of Glycyrrhiza 
glabra Linn. aqueous leaf extract. The extract showed a good dose dependent free 
radical scavenging activity in all the in-vitro models. However the extract showed 
only moderate scavenging activity of hydroxyl radical and anti lipid peroxidation 
potential which was performed using rat liver and brain homogenate. 
          Zafor sadeque and Zinnat Ara Begum et al., 2010 evaluated the protective 
effect of dried fruits of Glycyrrhiza glabra Linn. on hepatotoxicity in rats. The 
aqueous and ethanol extract of Glycyrrhiza glabra Linn. showed significant 
hepatoprotection against carbon tetrachloride induced hepatotoxicity. 
        Noriko otsuki et al., 2010 evaluated the anti-tumor activity and immuno 
modulatory effects of aqueous extract of Glycyrrhiza glabra Linn. leaves. It was 
observed that Glycyrrhiza glabra Linn. leaf extract showed a significant growth 
inhibitory on tumor cell lines and immuno modulatory effects. It was concluded that 
Glycyrrhiza glabra Linn.  leaf extract may potentially provide the means for the 
treatment and prevention of selected human diseases such as cancer, various allergic 
disorders and also serve as immuno adjuant for vaccine therapy. 
       Ahmad Nazrun et al., 2005 carried out a study to compare the rate of burn 
wound healing with the applications of the latex of Glycyrrhiza glabra Linn.  and 
silver sulfadiazine cream. It is found that there was no significant difference in the 
healing time of papaya latex treated group compared to the silver sulfadiazine treated 
group. 
         Nisar Ahmad et al., 2011 investigated the potential of Glycyrrhiza glabra Linn. 
leaf extract against Dengue fever in 45 year old patient bitten by carrier mosquitoes. 
The study showed that aqueous leaf extract exhibited potential activity against 
Dengue fever by increasing platelet count, WBC and neutrophil count. 
         Claudia da silva et al., 2010 evaluated the toxic and mutagenic potential of 
papain and its potential antioxidant activity against induced H2O2 oxidative stress in 
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Escherichia coli strain. The report showed negative results of papain on toxic and 
mutagenic potential and papain showed an activity protecting cells against H2O2 
induced oxidative stress. 
         Lohiya et al., 2002 evaluated the antifertility activity of the chloroform extract 
of Glycyrrhiza glabra Linn. seeds by oral administration in langar monkey. It was 
noticed that the extract gradually decreased the sperm concentration since days 30-60 
of treatment with total inhibition of sperm motility, a decrease in sperm viability and 
increase in sperm abnormality. Azospermia was observed after day 90 of treatment 
and continued during the whole treatment period. Treatment withdrawal resulted in a 
gradual recovery in these parameters and 150 days later they reverted to nearly the 
pretreatment values. 
        Taofeeq oduola et al., 2010 investigated the effect of Glycyrrhiza glabra Linn. 
on certain organs in wistar rats exposed to aqueous extract of unripe Glycyrrhiza 
glabra Linn. histopathological results showed that no pathological changes were 
observed in tissue sections of experimental animals when compared with tissue 
sections of same organs in control animals. 
        Indran et al., 2008 studied the effect of Glycyrrhiza glabra Linn. leaf aqueous 
extract on alcohol induced acute gastric damage and blood oxidative stress level. The 
results showed that gastric ulcer index was significantly reduced in rats pretreated 
with Glycyrrhiza glabra Linn. leaf extract as compared with alcohol treated controls. 
The extract offered some protection with reduction in plasma lipid peroxidation level 
with increased erythrocyte glutathione peroxidase activity. 
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OBJECTIVE AND PLAN OF WORK 
Liver plays major role in detoxification and excretion of many endogenous 
and exogenous compounds, any injury to it or impairment of its functions may lead to 
many implications on ones health. Management of liver diseases is still a challenge to 
the modern medicine. Unfortunately, conventional or synthetic drugs used in the 
treatment of liver diseases are inadequate and sometimes can have serious side 
effects. In the absence of a reliable liver protective drug in modern medicine there are 
a number of medicinal preparations in ayurveda recommended for the treatment of 
liver disorders. In view of severe undesirable side effects of synthetic agents, there is 
growing focus to follow systemic research methodology and to evaluate scientific 
basis for the traditional herbal medicines that are claimed to possess hepatoprotective 
activity.   
Glycyrrhiza glabra Linn. (Family; Fabaceae) is a short lived, fast growing 
woody large herb. The green fruit contains papain similar to pepsin, pulp of the fresh 
fruit contain a soft yellow resin, fat, albuminoid sugar and pectin. Leaves contain an 
alkaloid called carpine and a glycoside named carposide. A properly ripened papaya 
is juicy, sweetish and somewhat like a cantaloupe in flavor. The fruits contain papain 
which helps in digestion and is used to tenderize meat. Fruit of Glycyrrhiza glabra 
Linn. is a rich source of vitamin C. It also contains vitamin E, pectin and carotinoids. 
Fruits, latex and juice of Glycyrrhiza glabra Linn. have been reported to be used in 
dyspepsia, intestinal irritation, habitual constipation and chronic diarrhoea. 
Traditionally, the leaf extract was used as a tonic for the heart, analgesia and 
treatment of stomachache. The extract is also known to have antioxidant properties. 
Glycyrrhiza glabra Linn. has been reported to be useful in liver ailments and has been 
shown to possess hepatoprotective activity against carbon-tetrachloride induced liver 
damage in experimental animals. But a systematic research on any possible effect of 
Glycyrrhiza glabra Linn. leaves on paracetamol induced hepatotoxicity seems to be 
scarce. Hence, it is decided to evaluate the hepatoprotective activity of Glycyrrhiza 
glabra Linn. leaves against paracetamol induced hepatotoxicity in albino wistar rats.  
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PLAN OF WORK 
The leaves of Glycyrrhiza glabra Linn. was selected to screen for its 
hepatoprotective activity. Hence the plan of work was 
 Collection of leaf material. 
 Identification and authentification. 
 Extraction of dried leaf material by using Soxhlet apparatus. 
 Phytochemical test for Identification of chemical constituents. 
 Screening of hepatoprotective activity against paracetamol induced 
hepatotoxicity. 
 Determination of biochemical parameters. 
 Evaluation of In vivo Antioxidant activity. 
 Histopathological study. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
METHODOLOGY 
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MATERIALS AND METHODS 
 
4.1 PLANT MATERIAL 
 
The fresh leaves of Glycyrrhiza glabra Linn. were collected from ABS 
Botanical & Research Institute, Karipatty, Salem, Tamilnadu. The material was 
taxonomically identified, confirmed and authenticated by Prof.P.Jayaraman, 
ph.D.Director National Institute Of Herbal Science, Chennai  with authentication 
no PARC/2015/8113 and the voucher specimen was retained in our laboratory for 
further reference. The collected leaves were shade dried and the dried material was 
crushed to coarse powder with mechanical grinder. The powder was stored in air- 
tight container which was used for extraction. 
 
 
4.2 PREPARATION OF EXTRACT   
 
64 grams of powdered leaf material was defatted with petroleum ether (60
0
-
80
0
C) and then extracted with 95% methanol for 72 hrs using soxhlet apparatus. The 
extract obtained was concentrated to dryness under reduced pressure and the 
percentage yield was calculated.                                              
 
 4.3 CHEMICALS 
 Paracetamol as a gift sample from Chemosyn Ltd., Vapi, India. 
 Silymarin as a gift sample from Micro labs Ltd., Banglore, India. 
 Petroleum ether – Nice chemicals. Pvt Ltd, Cochin. 
 Methanol – Cheme pure Laboratory, Chennai. 
 CMC- Reachem Laboratory Chemicals Pvt Ltd, Chennai. 
 
 All other chemicals and reagents were of the analytical grades. 
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4.4 PHYTOCHEMICAL SCREENING 
The extract obtained was subjected to Preliminary Phytochemical screening. 
 
4.4.1 Test for alkaloids 
 
0.5gm of extract was dissolved in 10ml of dilute HCl (0.1N HCl) and filtered. 
The filtrate was used to test the presence of alkaloids.  
 
 Mayer’s test 
 
Filtrate was treated with Mayer’s reagent. Formation of yellow cream 
precipitate indicates the presence of alkaloids. 
 
 Dragendroff’s test 
 
Filtrate was treated with Dragendroff’s reagent. Formation of red colored 
precipitate indicates the presence of alkaloids. 
 Hager’s test 
 
Filtrate was treated with Hager’s reagent. Formation of yellow colored 
precipitate indicates the presence of alkaloids. 
 
 Wagner’s Test 
 
Filtrate was treated with wagner’s reagent. Formation of brown (or) reddish 
brown precipitate indicates the presence of alkaloids. (Rosenthalar, 1930) 
 
4.4.2 Detection of Phytosterols and Triterpenoids 
 
0.5gm of extract was treated with 10ml of chloroform and filtered. The filtrate 
was used to test the presence of phytosterols and Triterpenoids. 
 Libermann’s Test 
To 2ml filtrate in hot alcohol, few drops of acetic anhydride was added. 
Formation of brown precipitate indicates the presence of sterols. 
 Libermann’s Burchard Test 
 
 
100mg of extract was treated with 2ml of chloroform and filtered. To the filtrate 
few drops of acetic anhydride was added, boiled and cooled. Conc H2So4 was added 
through the sides of the test tube. Formation of brown ring at the junction indicates 
the presence of steroidal saponins. 
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 Salkowaski Test 
To the test extract solution few drops of Conc H2So4 was added, shaken and 
allowed to stand, lower layer turns red indicates the presence of sterols. (Peach and 
Tracey) 
 
4.4.3 Detection of Flavoniods 
 
 Shinoda Test 
 
To 100mg of extract, few fragments of magnesium metal were added in a test 
tube, followed by dropwise addition of Conc Hcl. Formation of magenta colour 
indicates the presence of flavonoids. 
 
 Alkaline Reagent Test 
 
To 100mg of extract, few drops of sodium hydroxide solution was added in a 
test tube. Formation of intense yellow color that becomes colorless on addition of few 
drops of dilute acid (Hcl) indicates the presence of flavanoids. (Shellard, 1957) 
 
 4.4.4 Detection of Saponins 
 
 Foam test 
 
The extract was diluted with 20ml of distilled water and it was shaken in a 
graduated cylinder for 15 minutes. A 1cm layer of foam indicates the presence of 
Saponins. 
 
 4.4.5 Detection of Proteins and Amino acids 
 
100mg of extract was taken in 10ml of water and filtered. The filtrate was used 
to test the presence of protein and amino acids. 
 
 Millon’s Test 
  
2ml of filtrate was treated with 2ml of millon’s reagent in a test tube and heated 
in a water bath for 5 minutes, cooled and few drops of NaNo2 was added. Formation 
of white precipitate, which turns to red upon heating, indicates the presence of 
proteins and amino acids. 
 
          Ninhydrin Test 
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2ml of filtrate, 0.25% ninhydrin reagent was added in a test tube and boiled for 
2 minutes. Formation of blue color indicates the presence of amino acids. 
 Biuret Test 
 
2ml of filtrate was treated with 2ml of 10% sodium hydroxide in a test and 
heated for 10 minutes. A drop of 7% copper sulphate solution was added in the above 
mixture. Formation of purplish violet indicates the presence of Proteins. (Finar, 1959) 
(Hawk, 1954) 
 
4.4.6 Detection of Fixed oils and Fats 
 Oil spot test: 
 
One drop of extract was placed on filter paper and the solvent was evaporated. 
An oily stain of filter paper indicates the presence of fixed oil. (Rosenthalar, 1930) 
 
  4.4.7 Detection of Phenolics and Tannins 
 
100mg of extract was boiled with 1ml of distilled water and filtered. The 
filtrate was used of the test. 
 
 Ferric chloride Test 
 
To 2ml of filtrate, 2ml of 1% ferric chloride was added in a test tube. 
Formation of bluish black color indicates the presence of Phenolic nucleus. 
 Lead acetate Test 
 
To 2ml of filtrate, few drops of lead acetate solution was added in a test tube. 
Formation of yellow precipitate indicates the presence of Tannins. 
 
4.4.8 Detection of Carbohydrate 
 
500mg of extract was dissolved in 5ml of distilled water and filtered. The 
filtrate was used to test the presence of carbohydrates. 
 Molisch’s test 
 
To one ml of filtrate, two drops of Molisch’s reagent was added in a test tube 
and 2ml of Conc H2So4 was added carefully along the side of the test tube. Formation 
of violet ring at the junction indicates the presence of carbohydrates. 
 Fehling’s test 
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To one ml of filtrate, 4ml of Fehling’s reagent was added in a test tube and 
heated for 10 minutes in a water bath. Formation of red precipitate indicates the 
presence of reducing sugar. 
 Benedicts Test 
 
Filtrate was treated with Benedict’s reagent and heated on water bath. 
Formation of orange red precipitate indicates the presence of reducing sugars. 
(Rosenthalar, 1930) 
4.4.9 Detection of Glycosides 
 
0.5gm of extract was hydrolyzed with 20ml of dilute Hcl (0.1N) and filtered. 
The filtrate was used to test the presence of glycosides. 
 Modified Borntrager’s test  
 
1ml of filtrate 2ml of 1% ferric chloride solution was added in a test tube and 
heated for 10 minutes in boiling water bath. The mixture was cooled and shaken with 
equal volume of benzene. The benzene layer was separated and treated with half its 
volume of ammonia solution. Formation of rose pink or cherry color in the ammonical 
layer indicates the presence of anthranol glycoside. 
 Legal’s test 
 
To 1ml of filtrate, 3ml of sodium nitropruside in pyridine and methanolic alkali 
(KoH) was added in a test tube. Formation of pink to blood red color indicates the 
presence of cardiac glycoside. 
 Keller Killiani Test 
 
 
Small portion from the extract was shaken with 1ml of Glacial acetic acid 
containing trace of ferric chloride. 1ml of Conc H2So4 was added carefully by the 
sides of the test tube. A blue color in the acetic acid layer and red color at the junction 
of two liquids indicate the presence of glycosides. (Hawk, 1954) 
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4.5 ACUTE ORAL TOXICITY STUDY OF METHANOL EXTRACT OF 
GLYCYRRHIZA GLABRA LINN. LEAVES 
Animals  
 
Swiss albino mice of female sex weighing 20-25gms were used for the study. 
The animals were obtained from Agricultural University, Mannuthy, Thrissur, kerala 
(328/99/CPCSEA) and were housed in polypropylene cages. The animals were 
maintained under standard laboratory conditions (25
0
 + 2
0
C; 12hr light and dark 
cycle). The animals were fed with standard diet and water ad-libitum. Ethical 
clearance (for handling of animals and the procedures used in study) was obtained 
from the Institutional Animal Ethical Committee (IAEC) before performing the study 
on animals. 
Acute oral toxicity study for methanol extract of Glycyrrhiza glabra Linn. a 
leaf was carried out as per OECD guidelines 425 (Up and Down procedure). The test 
procedure minimizes the number of animals required to estimate the acute oral 
toxicity. The test allows the observation of signs of toxicity and can also be used to 
identify chemicals that are likely to have low toxicity. Animals were fasted (food but 
not water was with held overnight) prior to dosing. The fasted body weight of each 
animal was determined and the dose was calculated according to the body weight. 
 
 Limit test at 2000mg/kg 
 
The drug was administered in the dose of 2000mg/kg body weight orally to 
one animal. If the test animal survived. Then four other animals were dosed 
sequentially; therefore, a total of five animals were tested. Animals were observed 
individually at least once during the first 30 minutes after dosing, periodically during 
the first 24 hours (with special attention given during the first 4 hour), and daily 
thereafter, for a total of 14 days. After the experimental period, the animals were 
weighed and humanely killed and their vital organs including heart, lungs, liver, 
kidneys, spleen, adrenals, sex organs and brain were grossly examined. (OECD 
Guidance; 2000) 
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4.6 EVALUATION OF HEPATOPROTECTIVE ACTIVITY 
 
Experimental Animals 
 
Male Albino rats of wistar strain weighing 150-200gm were used for the 
study. Animals were procured from Agricultural University Mannuthy, Thrissur, 
Kerala. (328/99/CPCSEA). The animals were maintained in animal house under 
standard environmental condition (25
0
+ 2
0
C) and 12hr/12hr light and dark cycle. 
Animals were fed with standard pellet diet and with water ad-libitum. The 
experimental protocol was approved by the Institutional Animal Ethical Committee 
N0: 887/2005/CPCSEA & experiments were conducted according to the CPCSEA, 
India guidelines on the use and care of experimental animals. 
 
 
Paracetamol induced hepatotoxicity 
 
Animals were divided into 5 groups of 6 animals each. 
 
Group-I  animals served as a control received 0.5%w/v carboxy methyl cellulose 
(CMC) 1ml/kg orally for 12 days, 
 
Group-II animals served as paracetamol intoxicated received paracetamol 1g/kg 
suspended in 0.5%w/v CMC solution orally till 7
th
 day, 
 
Group-III animals received paracetamol 1g/kg till 7
th
 day and methanol extract of 
Glycyrrhiza glabra Linn. 200mg/kg orally from day 4
th
 to day 12, 
 
Group-IV animals received paracetamol 1g/kg orally till 7
th
 day and methanol 
extract of Glycyrrhiza glabra Linn. 400mg/kg orally from day 4
th
 to 
day12. 
 
Group-V animals received paracetamol 1g/kg orally till 7
th
 day and silymarin 
100mg/kg orally from day 4
th
 to day 12, 
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4.7 BIOCHEMICAL ESTIMATION 
 
On 4
th
 and 13
th
 day all the animals were anesthetised with ketamine and blood 
was collected from retero orbital pluxes using fine glass capillary tube in clot 
activator tubes and allowed to clot. Serum was separated by centrifugation, the 
separated serum was used for estimation of 
Serum glutamic pyruvic transaminase (SGPT) 
 
Serum glutamic oxaloacetic transaminase (SGOT)   
 
Alkaline phosphatase (ALP) 
 
Total protein (TP) 
 
Total bilirubin (TB) 
 
Direct bilirubin (DB) 
 
Albumin (ALB) 
 
Globulin (GLOB) 
 
4.8 ESTIMATION OF SERUM BIOCHEMICAL PARAMETERS 
 
SGPT, SGOT, ALP, Total Protein, Albumin, was estimated using whole 
blood. All the above biochemical parameters were estimated using semi-auto analyzer 
(Photometer 5010 V5+, Germany) with enzymatic kits procured from Primal 
Healthcare limited, Lab Diagnostic Division, and Mumbai, India. 
A) ESTIMATION OF SGPT   
Serum Glutamate Pyruvate Transaminase (SGPT) 
Principle                                                     
L-Alanine +2-oxoglutarate       
ALAT
      L-Glutamate + Pyruvate 
Pyruvate + NADH + H⁺                         D-Lactate + NAD⁺ 
 
Addition of pyridoxal-5-phosphate (P-5-P) stabilizes the transaminases and 
avoids falsely low values in samples containing insufficient endogenous P-5-P, 
eg.from patients with myocardial infarction, liver diseases and intensive care patients. 
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Method 
 
Kinetic UV test, according to the international federation of clinical chemistry 
and laboratory medicine (IFCC) 
  
Table Shows reagents of SGPT in the kit 
 
Reagent-1 Concentration 
TRIS BUFFER  pH 7.5 100 mmol/l 
L-Alanine 500 mmol/l 
LDH (lactate dehydrogenase) ≥1200 U/l 
Reagent-2 Concentration 
2-Oxoglutarate 15mmol/l 
NADH 0.18 mmol/l 
Good’s buffer  pH  9.6 0.7mmol/l 
Pyridoxal -5-Phosphate 0.09 mmol/l 
 
 
Assay procedure 
 
Mix 800 µl of reagent-1 with 200 µl of reagent-2 in a 5 ml test tube 
 
a) To this, added 100 µl of serum. 
 
b) Mixed well and took the reading immediately. 
 
Normal range:   < 41 u/l 
 
 
B) ESTIMATION OF SGOT 
 
 
Serum  Glutamate  Oxaloacetate Transaminase (SGOT) 
 
 
Principle 
 
 
Alanine aminotransferase (ALAT) and aspartate amino transferase (ASAT) 
are the most important of a group of enzymes of aminotransferase. These enzymes 
acts as catalyst in conversion of α-keto acids in to amino acids by transfer of amino 
groups. 
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Increased levels of  ALAT is found in the hepatobillary disease condition 
where as increased ASAT levels occur in damaged conditions of heart and skeletal 
muscles well as liver parenchyma. Parallel measurement of ALAT and ASAT is 
therefore applied to distinguish liver from heart or skeletal muscle damages 
 
 
The ASAT/ALAT ratio is used from differential diagnosis of liver diseases 
     
L-Aspartate + 2-Oxaloglutarate      
ASAT
     L-Glutamate + oxaloacetate
 
   
 
 
Oxaloacetate + NADH + H⁺       MDH       D-Malate + NAD⁺ 
 
 
Method 
 
 
Optimized UV- test according to IFCC (International Federation of Clinical 
Chemistry and Laboratory Medicine) 
 
 
Table shows Reagents of SGOT in the kit 
 
Reagent-1 concentration 
TRIS BUFFER  pH 7.8 80 mmol/l 
L- Aspartate 240 mmol/l 
MDH(malate dehydrogenase) ≥600 U/l 
LDH(lactate dehydrogenase) ≥600 U/l 
Reagent-2 concentration 
2-Oxaloglutarate 12 mmol 
NADH 0.18 mmol 
Good buffer  pH   9.6 0.7 mmol/l 
Pyridoxal-5-Phosphate 0.09 mmol/l 
Assay procedure 
 
a) Mixed 800 µl of reagent-1 with 200 µl of reagent-2 in a 5 ml test tube 
 
b) To this, added 100 µl of serum 
 
c) Mixed well and took the reading immediately 
 
Normal range : <37u/l 
C) Alkaline phosphatase 
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Test principle 
 
Alkaline phosphatase (ALP), hydrolytic enzyme acting optimally at alkaline 
pH, exists in blood in numerous distinct forms which originate mainly from bone and 
liver                                                                        
 
 
p-Nitro phenyl phosphate +water         
ALP
         Phosphate + p-Nitro phenol 
 
Method 
 
Kinetic photometric test, according to the international Federation of clinical 
chemistry and laboratory Medicine (IFCC) 
 
Table   Shows reagents of Alkaline phosphatase in the kit 
 
Reagent 1 : Concentration 
2-Amino-2-methyl-1-propanol pH 10.4 0.35 mol/l 
Magnesium sulphate 2.0 mmol/l 
Zinc sulphate 1.0mmol/l 
HEDTA 2.0 mmol/l 
Reagent 2 : Concentration 
p-Nitrophenylphosphate 16.0mmol/l 
 
Test Procedure 
 
 
1.  Take 1000µl of reagent-1 in a5 ml test tube 
 
2.   To this add 250µl of reagent-2 and mix well 
 
3. Add 20µl of serum and mix well and take reading immediately and read 
absorbance at  405nm   
 
Normal range: 53-128 u/l 
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D) Total protein 
 
Principle 
 Protein forms a coloured complex with cupric ions in alkaline medium 
Table   Shows reagents of total protein in the kit 
Reagent-1 Concentration 
Cupric sulphate 6 mmol/l 
Potassium iodide 15 mmol/l 
Reagent-2 Concentration 
Protein (std) 6 g/100ml 
 
Method: Biuret method 
Procedure 
Preparation of test sample 
 1. Take 1ml of reagent-1in a5 ml test tube  
 
 2. To this add 0.02 ml of serum 
 
 3. Mix well and incubate at a room temperature for 15 min and Read the 
test sample   
 
Normal range: 3.2 to 4.2 g/dl 
 
E) Albumin 
Principle 
Albumin is bound by BCG dye to produce an increase in the blue green colour 
measured at 578 nm. The colour increase is proportional to concentration of albumin 
present.  
Low albumin (hypoalbuminemia) may be caused by liver disease, nephrotic 
syndrome, burns, protein-losing enteropathy, malabsorption, malnutrition, late 
pregnancy, genetic variations and malignancy. 
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High albumin (hyperalbuminemia) is almost always caused by dehydration. In 
some cases of retinol (Vitamin A) deficiency the albumin level can become raised to 
High-normal values (ex: 4.9 g/dL). This is because retinol causes cells to swell with 
water (this is also the reason too much Vitamin A is toxic) in lab experiments it has 
been shown that All-trans retinoic acid down regulates human albumin production. 
Method: bromocresol-green method 
Normal range: 3.8 to 4.4 g/dl 
(Roli Budhar and Sushil kumar, 2005) 
 
4.9 INVIVO ANTIOXIDANT ENZYME ESTIMATION 
 
On 13
th
 day animals were sacrificed after blood withdrawal and abdomen was 
cut open and liver was dissected out. 
 
 A portion of liver was washed with ice cold saline and the homogenate was 
prepared in 0.1M Tris Hcl buffer (p
H
7.4). The homogenate was centrifuged and 
supernatant was used for the assay of marker enzymes namely, 
 
Glutathione  (GSH) 
Glutathione peroxidase (GPx) 
Superoxide dismutase (SOD) 
Catalase (CAT) 
 
Total protein (TP) 
 
Lipid peroxidation (LPO) 
 
IN VIVO ANTI OXIDANT STUDIES
 
Preparation of tissue homogenate
 
The tissue were weighed and 10% tissue homogenate was prepared with 0.025 
M Tris -HCl buffer, pH 7.5.After centrifugation at 10,000 ×g for 10 min, the clear 
supernatant was used to measure thiobarbituric acid reactive substances(TBARS). 
For the estimation of non-enzymic and enzymic antioxidants, tissue was 
minced and homogenized (10% w/v) in 0.1 M phosphate buffer (pH 7.0) and 
centrifuged for 10 min and the resulting supernatant was used for enzyme assays. 
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A)  ENZYMATIC ANTIOXIDANT ACTIVITY 
1. ESTIMATION OF SUPEROXIDE DISMUTASE (SOD) ACTIVITY  
Reagents 
1. Adrenaline 
2. Carbonate buffer (pH10.2) 
3.  0.1Mm EDTA 
  The activity of superoxide dismutase (SOD) was assayed by the method of 
Kakkar et al based on the oxidation of epinephrine adrenochrome transition by 
enzyme. The post-mitochondrial suspension of mice liver (0.5ml) was diluted with 
distilled water (0.5).To this chilled ethanol (0.25ml) and chloroform (0.15ml) was 
added. The mixture was shaken for 1 min and centrifuged at 2000 × g for 10 min.The 
PMS (0.5ml) was added with PBS buffer (pH 7.2; 1.5ml).The reaction initiated by the 
addition of epinephrine(0.4ml) and change in optical density (O.D.,min-1) was 
measured at 470 nm.SOD activity was expressed as U/mg of tissue.Change in O.D 
(min-1) at 50% inhibition to adrenochrome transition by the enzyme was taken as one 
enzyme unit. 
2. ESTIMATION OF CATALASE (CAT) ACTIVITY 
Reagents 
 1. Dichromate/acetic acid reagent (5% solution of potassium dichromate in              
acetic acid  at 1:3 ratios) 
 
 2. 0.01 M Phosphate buffer, pH 7.0 
  
 3. 0.2 M Hydrogen peroxide 
Catalase(CAT) was estimated by the method of Sinha (1972).The reaction 
mixture (1.5ml vol) contained 1.0 ml of 0.01 M phosphate buffer (pH 7.0) 0.1 ml of 
tissue homogenate and 0.4 ml of 2M H2O2. The reaction was stopped by the addition 
of 2.0 ml dichromate-acetic acid reagent (5% potassium dichromate and glacial  acetic 
acid  were mixed in 1:3 ratio).Then thebabsorbance was measured at 530 nm; CAT 
activity was expressed as µM of H2O2 consumed/min/mg protein. 
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3.ESTIMATION OF GLUTATHIONE PEROXIDASE (GPX) ACTIVITY  
Reagents 
 1. 0.32 M Phosphate buffer, pH 7.0 
 2.  0.8 mM EDTA 
 3. 10 mM Sodium azide 
 4. 3 mM reduced glutathione 
 5. 2.5 mM H2O2 
 6. 10% TCA 
 7. 0.3 M Disodium hydrogen phosphate 
 8. DTNB solution (40 mg of DTNB in 100 ml of 1% sodium citrate) 
Procedure
 
Glutathione peroxidase (GPx) was measured by the method described by 
Rotruck et al.(1973).Briefly, the reaction mixture contained 0.2 ml 0.4 M phosphate 
buffer (pH 7.0),0.1 ml 10m M sodium azide,0.2 ml tissue homogenized in 0.4 M 
,phosphate buffer, pH 7.0,0.2 ml tissue homogenized in 0.4 M,phosphate buffer , pH 
7.0,0.2 ml reduced glutathione ,and 0.1 ml 0.2 mM hydrogen peroxide. The contents 
were incubated for 10 min at 37 ⁰c,0.4 ml 10% TCA was added to stop the reaction 
and centrifuged at 3200 × g for 20 min.The supernatant was assayed for glutathione 
content using Ellman’s  reagent (19.8 mg 5,5’-dithiobisnitrobenzoic acid (DTNB) in 
100 ml 0.1% sodium nitrate). The activities were expressed as µg of GSH consumed/ 
min/mg protein.  
B) NON ENZYMATIC ANTI OXIDANT ACTIVITY 
1.  ESTIMATION OF REDUCED GLUTATHIONE(GSH) ACTIVITY
 
Reagents 
 1. 10% TCA 
 2. 0.6 mM 5, 5’-dithiobis-2-nitrobenzoic acid (DTNB) in 0.2 M sodium 
phosphate 
 3. 0.2 M Phosphate buffer, pH 8.0 
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 Reduced glutathione (GSH)  was measured by the method of Ellman 
(1959).The PMS of rat liver (720 µl) and 5% TCA were mixed to precipitate the 
protein content of the supernatant.After centrifugation at 10,000 × g for 5 min, the 
supernatant was taken. DTNB (5,5’-dithio-bis(2-nitrobenzoic acid ) Ellman’s reagent 
was added to it and the absorbance was measured at 412nm. A standard graph was 
drawn using different concentration of standard GSH solution.GSH contents were 
calculated in the PMS of rat liver. 
2. ESTIMATION OF LIPID PEROXIDATION OF RAT LIVER AND 
KIDNEYS 
Reagents 
1. Thiobarbituric acid 0.37% 
2. 0.25 N HCl 
3. 15% TCA 
Lipid peroxidation in liver and kidney was estimated calorimetrically by 
measuring thiobarbituric acid reactive substances (TBARS) using the method of Fraga 
et al. (1988). In brief, 0.1 ml of tissue homogenate was treated with 2 ml of TBA-
trichloroacetic acid –HCl reagent (0.37% TBA, 0.25 M HCl and 15% TCA, 1:1:1 
ratio), placed for 15 min in a water bath and then cooled and centrifuged at 3500 ×g 
for 10 min at room temperature, the absorbance of clear supernatant was measured at 
535 nm against a reference blank. Values were expressed as Mm/100 g tissue. 
C)  ESTIMATION OF PROTEINS 
Principle 
Procedure described by Lowery et al (1951) was used for protein estimation. 
The method is based on the biuret reaction, formation of a protein-copper complex 
and reduction of phosphomolybdo tungstate reagent (Folin-ciocalteu phenol reagent) 
by tyrosine and tryptophan residues of protein to form a coloured product. 
Reagents 
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Solution A: 1ml CuSO4 5H2O (1%) + 1ml sodium potassium tarterate (2%) + 
98 ml 2% Na2CO3 in 0.1N NaOH.Solution B: Folin Ciocalteu reagent and distilled 
water mixed in 1:1 ratio just before use. 
Procedure 
0.01 ml of tissue homogenate (2.5%) was diluted to 1.2 ml and mixed with 6 ml of 
solution A. The mixture was incubated at room temperature for 10 min and add 0.3 ml 
solution B was added, mixed immediately and kept at room temperature for 30 min. 
optical density was taken  at 750 nm. The amount of protein was calculated from the 
standard curve of bovine serum albumin (BSA). (Resat Ozaras et al., 2003) 
(Edakkadath et al., 2010) (Nanu et al., 2008) 
 
4.10 HISTOPATHOLOGICAL INVESTIGATIONS 
A portion of liver processed for histopathological investigations. 
 Histophatological techiniques 
Histopathology is the microscopical study of tissues for pathological 
alterations. This involves collection of morbid tissues from biopsy or necropsy, 
fixation, preparation of sections, staining and microscopical examination. 
 Collection of materials 
Thin pieces of 3 to 5 mm, thickness are collected from tissues showing gross 
morbid changes along with normal tissue. 
 Fixation 
Keeping the tissue in fixative for 24-48 hours at room temperature 
a) Serves to harden the tissues by coagulating the cell protein, 
b) Prevents autolysis,  
c) Preserves the structure of the tissue, and  
d) Prevents shrinkage: The volume of the fixative added is 10times the volume 
of the tissues. Common Fixatives: 10% Formalin.                             
 Haematoxylin and eosin method of staining 
Chapter -4                                                                                Materials and Methods  
 
 
 
                Deparaffinise the section by xylol 5 to 10 minutes and remove xylol by 
absolute alcohol, then wash in tap water. Stain with haematoxylin for 3-4 minutes and 
wash in tap water. Allow the sections in tap water 5-10 min and wash in tap water. 
Counter stain with 0.5% until section appears light pink (15 to 30seconds), and then 
wash in tap water. Blot and dehydrate in alcohol. Clear with xylol (15 to 30 seconds). 
Mount in Canada balsam or DPX Moutant. Keep slide dry and remove air bubbles. 
4.11 STATISTICAL ANALYSIS                
          All the grouped data were expressed as mean +SEM. The results were analysed 
for statistical significance using ONE-WAY ANOVA followed by DUNNET’S 
TEST. P values < 0.05 were considered as significant. (Mukesh Tanwar et al., 2011) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         RESULTS  
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RESULTS AND DISCUSSION 
 
Table 1.  Percentage yield of methanol extract of Glycyrrhiza glabra Linn. 
leaves 
 
 
Solvent Percentage yield (w/w) 
Methanol 38.5% 
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Table 2.  Phytoconstituents detected in methanol extract of Glycyrrhiza glabra Linn. 
leaves 
 
S. No. Test Inference 
1. 
Test for Alkaloids 
a. Mayer’s test 
b. Dragendroff’s 
c. Hager’s test 
d. Wagner’s test 
 
+ 
+ 
+ 
+ 
2. 
Test for Phytosterols and Triterpenoids 
a. Leibermann’s test 
b. Leiberman-Burchard 
c. Salkowaski test 
 
 
+ 
+ 
+ 
3. 
Test for Flavonoids 
a. Alkaline reagent test 
- 
4. 
Test for Saponins 
a. Foam test 
 
- 
5. 
Test for Proteins and Amino acids 
a. Millon’s test 
b. Ninhydrin test 
c. Biuret test 
 
 
+ 
- 
+ 
6. 
Test for fixed oils and fats 
a. Oily spot test 
 
- 
7. 
Test for Phenolics and Tannins 
a. Ferric chloride test 
b. Lead acetate test 
 
+ 
+ 
8. 
Test for carbohydrates 
a. Molisch’s test 
b. Fehling’s test 
c. Benedict’s test 
 
+ 
+ 
+ 
9. 
Test for  Gylcosides 
a. Modified Borntrager’s test 
b. Legal’s test 
c. Keller-Killiani test 
 
+ 
+ 
+ 
 
 
       (+) Present,  (-) Absent. 
 
Chapter -5                                                                                Results and Discussion   
 
 
 
 
TABLE 3.  Acute oral Toxicity study (425) observations 
 
RESPIRATORY BLOCKAGE IN NOSTRIL  
Dyspnoea Nil 
Apnoea Nil 
Tachypnea Nil 
Nostril discharge Nil 
MOTOR ACTIVITIES 
Locomotion Normal 
Somnolence Nil 
Loss of righting reflex Nil 
Anaesthesia Nil 
Catalepsy Nil 
Ataxia Nil 
Toe walking Nil 
Prostration Nil 
Fasciculation Nil 
Tremor Nil 
CONVULSION (INVOLUNTRAY CONTRACTION) 
Clonic/tonic/tonic-clonic convulsion Nil 
Asphyxial convulsion Nil 
Opistotones (titanic spasm) Nil 
REFLEXES 
Corneal Normal 
Eyelid closure Normal 
Righting Normal 
Light Normal 
Auditory and sensory Normal 
OCULAR SIGNS 
Lacrimation Nil 
Chapter -5                                                                                Results and Discussion   
 
 
 
Miosis Nil 
Mydriasis Nil 
Ptosis Nil 
Chromodacryorrhea Nil 
Iritis Nil 
Conjunctivitis Nil 
SALIVATION 
Saliva secretion Nil 
PILOERECTION  
Contraction of erectile tissue Nil 
ANALGESIA 
Decrease in reaction to induced pain Nil 
MUSCLE TONE 
Hypo or hypertonia Nil 
GIT SIGN 
Solid  dried / watery stool Nil 
Emesis Nil 
Red urine Nil 
SKIN 
Oedema  Nil 
Erythema Nil 
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Table 4. Effect of methanol extract of Glycyrrhiza glabra Linn. leaves on 
biochemical parameters in paracetamol intoxicated rats. 
Groups Day 
SGOT 
(IU/L) 
SGPT 
(IU/L) 
ALP 
(IU/L) 
TP 
(g/dl) 
TB 
(mg/dl) 
DB 
(mg/dl) 
ALBUMIN 
(g/dl) 
GLOBULIN 
(g/dl) 
Group-I 
Control 
(0.5%w/v 
CMC 
1ml/kg) 
Day 
4 
32.67 
±2.21 
27.50 
±2.84 
50.50 
±3.08 
7.167 
±0.28 
0.8500 
±0.10 
0.4683 
±0.14 
3.383 
±0.11 
4.017 
±0.64 
Day 
13 
36.33 
±3.19 
29.83 
±3.39 
61.17 
±8.02 
6.467 
±0.64 
0.9500 
±0.23 
0.5300 
±0.15 
3.167 
±0.23 
3.117 
±0.39 
Group-II 
Paracetamol 
Intoxicated 
(1g/kg) 
Day 
4 
52.83 
±3.37***a 
50.50 
±2.70***a 
139.7 
±8.7***a 
5.900 
±0.47*a 
1.900 
±0.04**a 
0.5717 
±0.12nsa 
2.183 
±0.23**a 
2.817 
±0.64nsa 
Day 
13 
 
57.33 
±2.44***a 
47.33 
±2.94***a 
149.0 
±4.21***a 
3.000 
±0.09***a 
2.072 
±0.09***a 
0.6400 
±0.11nsa 
1.750 
±0.09***a 
1.317 
±0.06***a 
Group-III 
Glycyrrhiza 
glabra 
extract 
(200mg/kg) 
Day 
4 
52.67 
±3.70nsb 
50.17 
±4.34nsb 
131.8 
±7.36nsb 
5.417 
±0.33nsb 
1.918 
±0.20nsb 
1.068 
±0.12*b 
2.068 
±0.37nsb 
2.933 
±0.12nsb 
Day 
13 
49.67 
±2.01*b 
43.33 
±1.28nsb 
53.33 
±1.92***b 
3.967 
±0.29*b 
1.233 
±0.04***b 
0.6000 
±0.09nsb 
2.417 
±0.34nsb 
3.100 
±0.10***b 
Group-IV 
Glycyrrhiza 
glabra 
extract 
(400mg/kg) 
Day 
4 
57.33 
±1.11nsb 
52.00 
±0.44nsb 
141.0 
±5.50nsb 
4.817 
±0.08nsb 
2.233 
±0.21nsb 
1.067 
±0.09*b 
2.233 
±0.12nsb 
1.867 
±0.14nsb 
Day 
13 
35.67 
±0.66***b 
27.83 
±0.54***b 
40.33 
±7.31***b 
5.900 
±0.25***b 
0.7150 
±0.10***b 
04433 
±0.07nsb 
4.217 
±0.07***b 
3.767 
±0.28***b 
Group-V 
Silymarin 
(100mg/kg) 
Day 
4 
54.0 
±1.39nsb 
49.50 
±0.88nsb 
115.5 
±4.53nsb 
6.067 
±0.21nsb 
1.517 
±0.24nsb 
0.7167 
±0.11nsb 
2.600 
±0.26nsb 
3.067 
±0.85nsb 
Day 
13 
29.67 
±1.20***b 
23.33 
±1.00***b 
46.67 
±3.38***b 
3.717 
±0.18nsb 
0.2433 
±0.02***b 
0.1100 
±0.01***b 
3.750 
±0.15***b 
3.650 
±0.30***b 
          
 
All the values expressed as mean ± SEM, n=6 in each group. 
a values are significantly different from control group. ns; p*<0.05; p**<0.01; p***0.001. 
b values are significantly different from paracetamol intoxicated group. ns; p*<0.05; p**<0.01; p***<0.001. 
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   FIG 3. SGOT LEVEL ON 4
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 DAY         FIG 4. SGOT LEVEL ON 13
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FIG 5. ALP LEVEL ON 4
TH
 DAY                FIG 6. ALP LEVEL ON 13
TH
 DAY 
 
                       
 
 
 
 
 
 
      
 
 FIG 7. TOTAL PROTEIN  LEVEL ON                     FIG 8. TOTAL PROTEIN LEVEL ON 
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FIG 9. TOTAL BILURUBIN LEVEL                 FIG 10. TOTAL BILIRUBIN LEVEL ON 
ON 4
TH
 DAY                                                                   13
TH
 DAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 11. DIRECT BILIRUBIN LEVEL ON                 FIG 12. DIRECT BILIRUBIN LEVEL ON 
                  4
TH
 DAY                     13
TH
 DAY 
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FIG 13. ALBUMIN LEVEL                         FIG 14. ALBUMIN LEVEL 
ON 4
TH
 DAY                                               ON 13
TH
 DAY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 15. GLOBULIN LEVEL                  FIG 16. GLOBULIN LEVEL 
ON 4
TH
 DAY                                          ON 13
TH
 DAY 
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Table 5. Effect of methanol extract of Glycyrrhiza glabra Linn. on liver weight in 
paracetamol intoxicated rats. 
S. No Groups Treatment Dose 
Weight of Liver 
(gms) 
1 Group-I Control 
0.5%w/v CMC 
1ml/kg 
4.675±0.36 
2 Group-II 
Paracetamol 
intoxicated 
1g/kg 6.352±0.45
**a 
3 Group-III 
Glycyrrhiza 
glabra extract 
200mg/kg 6.196±0.12
nsb 
4 Group-IV 
Glycyrrhiza 
glabra extract 
400mg/kg 5.300±0.24
*b 
5 Group-V Silymarin 100mg/kg 4.855±0.22
**b 
 
All the values expressed as mean ± SEM, n=6 in each group. 
 
a 
values are significantly different from control group. ns; p
*
<0.05; p
**
<0.01; p
***
0.001. 
 
b 
values are significantly different from paracetamol intoxicated group. ns; p
*
<0.05; p
**
<0.01; 
p
***
<0.001. 
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FIGURE 17. Effect of methanol extract of Glycyrrhiza glabra Linn. on liver 
weight in paracetamol intoxicated rats. 
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Table 6. Effect of methanol extract of Glycyrrhiza glabra Linn. on liver enzymes 
in paracetamol intoxicated rats. 
GROUPS 
SOD 
(U/mg of 
protein) 
CATALASE 
(U/mg of 
protein) 
GSH 
(n 
mol/mg 
of 
protein) 
GPX 
(U/mg of 
protein) 
TP 
(n 
mol/mg 
of 
protein) 
LPO  
(MDA 
umol/hr/gr 
of tissue) 
Group - I 
Control 
(0.5% w/v 
CMC 1ml/kg 
0.351 
±0.01 
1.698 
±0.07 
1.183 
±0.008 
0.520 
±0.03 
2.428 
±0.01 
0.103 
±0.008 
Group - II 
Paracetamol 
Intoxicated 
(1gr/kg) 
0.163 
±0.01
***a
 
0.635 
±0.05
***a 
0.068 
±0.01
***a 
0.193 
±0.01
***a 
1.698 
±0.17
***a 
0.328 
±0.02
***a
 
Group - III 
Glycyrrhiza 
glabra 
(200mg/kg) 
0.231 
±0.01
**b 
0.905 
±0.02
**b 
0.866 
±0.05
***b 
0.251 
±0.006
*b 
2.865 
±0.15
***b 
0.210 
±0.01
***b 
Group - IV 
Glycyrrhiza 
glabra 
(400mg/kg) 
0.280 
±0.01
***b
 
1.400 
±0.07
***b 
1.660 
±0.07
***b 
0.275 
±0.005
***b 
3.018 
±0.09
***b 
0.165 
±0.009
***b 
Group - V 
Silymarin 
(100mg/kg) 
 
0.320 
±0.006
***b
 
1.635 
±0.06
***b 
1.183 
±0.007
***b 
0.553 
±0.01
***b 
2.362 
±0.06
**b 
0.103 
±0.01
***b 
 
All the values expressed as mean ± SEM, n=6 in each group. 
 
 
a 
values are significantly different from control group.ns; p
*
<0.05; p
**
<0.01; 
p
***
0.001. 
 
b 
values are significantly different from paracetamol intoxicated group. ns; p
*
<0.05; 
p
**
<0.01; p
***
<0.001. 
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Effect of methanol extract of Glycyrrhiza glabra Linn. on liver enzymes in 
paracetamol intoxicated rats.  
         FIG 18. SUPEROXIDE DISMUTASE                    FIG 19. CATALASE 
 
 
 
 
 
 
 
 
 
 
 
 
FIG 20. GLUTATHIONE REDUCTASE    FIG 21. GLUTATHIONE  PEROXIDASE 
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            FIG 22. TOTAL PROTEIN             FIG 23. LIPID PEROXIDATION 
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FIGURE 24. Section of the liver tissue of control rat showing normal histology, 
central vein surrounded by cords of hepatocytes. 
                 
                                                                                 
 
 
 
 
 
[H & E, X 10] 
 
FIGURE 25. Section of liver tissue of paracetamol intoxicated rat Showing cellular 
degeneration, necrosis, vacuolar degeneration and inflammatory changes. 
                   
 
 
 
 
 
 
[H & E, X 10] 
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FIGURE 26. Section of liver tissue of rat treated with methanol extract of 
Glycyrrhiza glabra Linn. leaves 200mg/kg showing less centrilobular necrosis, mild 
degree of inflammation and fatty changes. 
                 
 
 
 
 
 
 
[H & E, X 10] 
FIGURE 27. Section of liver tissue of rat treated with methanol extract of 
Glycyrrhiza glabra Linn. leaves 400mg/kg showing normal arrangement of 
hepatocytes with no evidence of congestion in central veins and sinusoids. 
                 
 
 
 
 
 
 
 
                        [H & E, X 10] 
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FIGURE 28. Section of liver tissue of rat treated with Silymarin 100 mg/kg showing 
normal histological appearance with no evidence of necrosis.   
 
                    
 
 
 
      
 
   
 
                                                                           [H & E, 10] 
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PERCENTAGE YIELD 
             The yield of Glycyrrhiza glabra Linn. leaf extract obtained by soxhlet 
apparatus using methanol as solvent for 72hrs was found to be 35%w/w. The results 
are shown in Table no 1. 
PHYTOCONSTITUENTS 
             The preliminary phytochemical study of leaf extract showed the presence of 
alkaloids, phytosterols, triterpenoids, proteins, aminoacids, phenolics, tannins, 
carbohydrates and glycosides. The results are shown in Table no 2. 
ACUTE ORAL TOXICITY STUDY 
             A preliminary toxicity study was designed to demonstrate the appropriate 
dose range that could be used for subsequent experiments rather than to provide 
complete toxicity study data of the extract. Acute toxicity study reveiled that the 
administration of methanol extract of Glycyrrhiza glabra Linn. leaves up to a dose 
level of 2000mg/kg did not produce significant changes in behavior, breathing, 
cutaneous effects, sensory, nervous system responses and gastro intestinal effects in 
mice. The animals were physically active no lethality or adverse signs were seen 
during the experimental period. During 14
th
 days observation period no delayed signs 
of toxicity were noted in experimental animals. All the animals behave normally. No 
significant change in body weight was deducted on 14
th
 day. There was no difference 
in appearance of internal organs in gross examination. From the results it was 
observed that methanol extract of Glycyrrhiza glabra Linn. leaves at the dose of 
2000mg/kg were non toxic. The observation of acute oral toxicity study of methanol 
extract of Glycyrrhiza glabra Linn. leaves were shown in Table no 3. 
 
BIOCHEMICAL PARAMETERS 
         The serum biochemical parameters were analysed on 4
th
 day and 13
th
 day of 
evaluation. The hepatic enzymes SGOT, SGPT, ALP and BILIRUBIN were 
significantly increased (0.001) in paracetamol intoxicated rats on 4
th
 day and it 
remained significantly high on 13
th
 day of evaluation compared to control group 
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animals. Serum albumin, Globulin and Total protein were significantly reduced in 
paracetamol intoxicated animals on day 4
th
 and day 13
th
 compared to normal animals. 
  Administration of methanol extract of Glycyrrhiza glabra Linn. controlled the 
paracetamol induced hepatotoxicity in rats. No significant difference in biochemical 
parameters were noted on day 4 between the treatment groups and paracetamol 
intoxicated group. 
        On day 13 evaluation, methanol extract of Glycyrrhiza glabra Linn. showed a 
significant (P<0.001) protection against paracetamol intoxication by attenuating 
SGOT, SGPT, ALP and TOTAL BILIRUBIN evaluation. A significant increase in 
protein levels were noted in extract treated animals. The effect of methanol extract of 
Glycyrrhiza glabra Linn. was found to be dose dependent. However protection 
offered by Silymarin seemed relatively greater. The results are shown in table and 
figure. (Table no 4) (Figure no 1-16) 
LIVER WEIGHT 
         A significant increase in liver weight was observed in paracetamol intoxicated 
rats compared to normal rats (P<0.01). Methanol extract of Glycyrrhiza glabra Linn. 
leaves at a range of 400mg/kg showed hepatoprotection by reducing the liver weight 
of paracetamol intoxicated rats. A significant difference (P<0.05) was noted between 
extract treated group and paracetamol intoxicated group, but 200mg/kg was not 
effective in reducing paracetamol induced increase in liver weight, no significant 
difference in liver weight was observed between extract 200mg/kg and paracetamol 
intoxicated group (ns). Silymarin treated animals showed a marked reduction in liver 
weight compared to paracetamol intoxicated. The results are highly significant 
(p<0.01). (Table no 5) (Figure no 17) 
[ 
INVIVO ANTIOXIDANT ENZYMES   
The influence of paracetamol intoxication and the effects of methanol extract 
of Glycyrrhiza glabra Linn. leaves on the antioxidant enzyme activities were shown 
in Table no 6 and Figure no 18-23. 
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Lipid peroxidation (LPO) 
 
Lipid peroxidation level of liver homogenates significantly increased 
(P<0.001) in paracetamol intoxicated rats compared to control rats. Treatment with 
methanol extract of Glycyrrhiza glabra Linn. leaves showed a significant (P<0.001) 
decrease in LPO in liver homogenate when compared with paracetamol intoxicated 
rats.  
Glutathione (GSH) 
                 The tissue glutathione was found to be depleted in paracetamol intoxicated 
group, compared to control group animals (P<0.001) which indicates the tissue 
damage caused by generation of free radicals. Administration of Glycyrrhiza glabra 
Linn. leaf extract restored the depleted glutathione. A significant increase in 
glutathione level was found in extract treated groups. Administration of 400mg/kg 
extract showed significant increase (P<0.001) compared to 200mg/kg (P<0.01). 
 
Superoxide dismutase (SOD) 
SOD level was significantly reduced (P<0.001) in paracetamol intoxicated rats 
compared with normal animals. Administration of methanol extract of Glycyrrhiza 
glabra Linn. leaves showed a significant increase in SOD levels. Extract at a dose 
level of 400mg/kg was highly significant (P<0.001) compared to 200mg/kg (P<0.01) 
dose level. 
Glutathione peroxidase (GPX) 
The level of GPX was significantly reduced (P<0.001) in paracetamol 
intoxicated group compared to normal animals which was restored by methanol 
extract of Glycyrrhiza glabra Linn. leaves. Extract at dose level 400mg/kg was highly 
significant (P<0.001) compared to 200mg/kg (P<0.05). 
Total protein (TP) 
A significant decrease in liver protein (P<0.001) was observed in liver tissue 
of paracetamol intoxicated rats compared to normal rats. Administration of methanol 
extract of Glycyrrhiza glabra Linn. leaves restored the protein levels. The increase in 
protein was significant (P<0.001) with 400mg/kg dose level compared to dose level of 
200mg/kg dose level (P<0.01). 
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Catalase (CAT) 
Catalase was significantly reduced (P<0.001) in paracetamol intoxicated rats 
compared to normal rats. Administration of methanol extract of Glycyrrhiza glabra 
Linn. leaves increased the catalase to significant level compared to paracetamol 
intoxicated. The increase was found to highly significant with 400mg/kg extract 
compared to 200mg/kg dose level. 
HISTOPATHOLOGICAL EXAMINATION 
The histopathological examination of control group showed normal structure 
and architecture. No evidence of portal inflammation, degeneration or fatty change 
and necrosis. The results are shown in Figure 24. 
Paracetamol intoxicated rats showed clear cellular degeneration and loss of the 
distinct liver characteristic configuration. Centrilobular necrosis and necrosis in all 
area of lobule were observed. Congestion in central veins and sinusoids were noted. 
Vacuolar degeneration   and inflammatory changes associated with fatty changes were 
noted. The results are shown in Figure 25. 
The section of liver treated with methanol extract of Glycyrrhiza glabra Linn. 
leaves 200 mg/kg showed less centrilobular necrosis. Central vein and sinusoid 
congestion were   not observed. Mild degree of inflammation and fatty changes were 
noted. The results are   shown in Figure 26. 
Treatment with 400 mg/kg methanol extract of Glycyrrhiza glabra Linn. 
leaves showed a pathological protection to liver. The section of liver showed more or 
less normal architecture of liver, no degeneration, no evidence of congestion in central 
veins and sinusoids. Necrotic lesions and fatty changes were observed. A dose 
dependent protection of methanol extract of Glycyrrhiza glabra Linn. leaves were 
observed in histopathological examination. Papaya leaf extract in higher dose showed 
better protection against liver damage. The results are shown    in Figure 27. 
The section of liver treated with Silymarin 100 mg/kg body weight showed 
almost normal architecture of the liver to control the animal. The results are shown in 
Figure 28. 
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DISCUSSION 
Paracetamol is a known antipyretic and analgesic which produces hepatic 
necrosis in high doses. Paracetamol is normally eliminated mainly as sulfate and 
glucuronide. Administration of toxic doses of paracetamol cause the sulfation and 
glucuronidation routes become saturated and hence, higher percentage of paracetamol 
molecules are oxidized to highly reactive N-acetyl-para-benzoquinonimine by 
cytochrome P450 enzymes. Semiquinone radicals, obtained by one electron reduction 
of N-acetyl-para- benzoquinonimine, can covalently binds to macromolecules of 
cellular membrane and increases the lipid peroxidation resulting in liver damage. 
 
Damage induced in liver by paracetamol is accompanied by increase in the 
activity of some serum enzymes. The study of different enzyme activities such as 
SGOT, SGPT, ALP, TOTAL BILIRUBIN and TOTAL PROTEIN have been found to 
be of great value in the assessment of clinical and experimental liver damage. 
 
The efficacy of any hepatoprotective drug is dependent on its capacity of 
either reducing the harmful effect or restoring the normal hepatic physiology that has 
been disturbed by a hepatotoxin.  
 
Necrosis or membrane damage releases the enzyme in to circulation and hence 
it can be measured in serum. High levels of SGOT indicates liver damage, such as 
that caused by viral hepatitis as well as cardiac infraction and muscle injury. SGPT 
catalyses the conversion of alanine to pyruvate and glutamate and is released in 
similar manner. Therefore SGPT is more specific to the liver and is thus a better 
parameter for detecting liver injury. Elevated levels of serum enzymes are indicative 
of cellular damage and loss of functional integrity of cell membrane in liver.  The 
ability of the methanol extract of Glycyrrhiza glabra Linn. leaves to prevent the 
increase in the activities of these enzymes is primary evidence indicative of 
hepatoprotective activity. 
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Elevated ALP level may indicate cholestasis (partial or full blockade of bile 
ducts). Since bile ducts bring bile from the liver in to gall bladder and intestine, 
inflammation/damage of the liver can cause spillage of ALP in to the blood stream. 
ALP levels typically rise to several times the normal level following the bile 
obstruction or intra hepatic cholestasis. Causes of elevated ALP also include biliary 
cirrhosis, fatty liver and liver tumor. The highest serum ALP elevation often greater 
than 1000U/L or more than six times the normal value are found in diffuse infiltration 
of the liver and the biliary tract. Significant reduction in ALP levels in the extract 
treated groups indicated that the Glycyrrhiza glabra Linn. leaves were offer protection 
to the liver against acetaminophen induced hepatotoxicity. 
 
Bilirubin is a yellow pigment produced when heme is catabolised. 
Hepatocytes render bilirubin water-soluble and therefore easily excretable by 
conjugating it with glucuronic acid prior to secreting it into bile by active transport. 
Hyper bilirubinemia may result from the production of more bilirubin then the liver 
can process, damage to the liver impairing its ability to excrete normal amount of 
bilirubin or obstruction of excretory ducts of the liver. Serum bilirubin is considered 
as one of the true test of liver functions since it reflects the ability of the liver to take 
up and process bilirubin into bile. Elevated levels may indicate several illness. High 
levels of total bilirubin in acetaminophen treated rats may be due to acetaminophen 
toxicity. This may have resulted in hyper bilirubinemia. The significant reduction in 
the level of total bilirubin in the serum of Glycyrrhiza glabra Linn. leaf extract treated 
rats suggested the hepatoprotective potential of leaf extract against acetaminophen 
intoxication. 
                  The reduction in the serum albumin and globulin levels in acetaminophen 
intoxicated group might be due to liver damage. Hepatotoxicity impairs the synthetic 
function of the liver. Treatment with methanol extract of Glycyrrhiza glabra Linn. 
leaves ameliorated the imbalance.    
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 IN VIVO ANTIOXIDANT ENZYMES 
 
The body has an effective mechanism to prevent and neutralize the free radical 
induced damage. This is accomplished by a set of endogenous antioxidant enzymes, 
such as Glutathione peroxidase, Glutathione reductase, Superoxide dismutase and 
Catalase. When the balance between ROS production and antioxidant defense is lost, 
oxidative stress results, which through a series of events deregulates the cellular 
functions leading to various pathological conditions. Any compound, natural or 
synthetic, with antioxidant properties might contribute towards the partial or total 
alleviation of this type of damage. 
[Lipid peroxidation (LPO) has been postulated as being the destructive process 
in liver injury due to paracetamol administration. The excessive ROS generated 
during acetaminophen metabolism rapidly reacts with lipid membranes. This initiates 
lipid peroxidation chain reaction, which produces lipid peroxy radicals. Enhanced 
hepatic MDA, a major reactive aldehyde resulting from the peroxidation of poly 
unsaturated fatty acids in the cell membrane, reflects a casual role of lipid 
peroxidation in paracetamol-induced liver damage. Treatment with methanol extract 
of Glycyrrhiza glabra Linn. leaves exhibited a significant inhibitory role against lipid 
peroxidation in rats and there by diminished paracetamol induced hepatic membrane 
destruction and hepatic damage. The prevention of lipid peroxidation might, at least in 
part, be derived from the capability of Glycyrrhiza glabra Linn. Leaves to scavange 
ROS. 
 
Glutathione (GSH), extensively found in cells, protects cells against 
electrophilic attacks provided by xenobiotics such as free radicals and peroxides. GSH 
deficiency leades to cellular damage in kidney, muscle, lung, jejunum, colon, liver, 
lymphocytes and brain. The elevation of MDA level, which is one of the end products 
of lipid peroxidation in the liver tissue, and the reduction in hepatic GSH levels are 
important indicators in paracetamol intoxicated rats. In this study, it was ascertained 
that MDA levels have been suppressed  compared to paracetamol intoxicated group 
and paracetamol induced depletion of GSH was prevented. 
 
Chapter -5                                                                                Results and Discussion   
 
 
 
Catalase (CAT) is an enzymatic antioxidant widely distributed in all tissues 
and the highest activity is found in red cells and liver. Catalase is a heme protein, 
localized in the peroxisomes or the microperoxisomes. This enzyme catalyses the 
decomposition of H2O2 to water and oxygen and thus protecting the cell from 
oxidative damage by H2O2 and OH. Therefore, the reduction in the activity of catalase 
may result in a number of deleterious effects due to accumulation of hydrogen 
peroxide. In the present study, treatment with methanol extract of Glycyrrhiza glabra 
Linn. leaves increased the level of catalase significantly in dose dependent manner 
and protected the liver from paracetamol intoxication. 
 
 
Superoxide dismutase (SOD), a metallo protein is the most sensitive enzyme 
index in liver injury and one of the most important enzyme in the enzymatic 
antioxidant defense system. It scavenges the superoxide anion to form hydrogen 
peroxide and oxygen, hence diminishing the toxic effect caused by this radical. In the 
present study, it was observed that the methanol extract of Glycyrrhiza glabra Linn. 
leaves significantly increased the SOD activity in paracetamol intoxicated rats there 
by diminished paracetamol induced oxidative damage.  
 
Glutathione peroxidase (GPX) is a seleno enzyme two third of which (in liver) 
is present in the cytosol and one third in the mitochondria. It protects cells from 
damage due to free radicals like hydrogen and lipid peroxides. It catalyzes the 
reaction of hydroperoxidases with reduced glutathione to form glutathione disulphide 
and the reduction product of hydroperoxide. In the present study, decline in activity of 
glutathione peroxidase has been associated with oxidative stress elicted of 
Glycyrrhiza glabra Linn. leaves significantly increased the level of glutathione 
peroxidase in a dose dependent manner. 
Protein is the most important and biochemical constituent present in the body. 
Proteins are important in all biological system. It plays a major role in the synthesis of 
microsomal detoxifying enzymes and helps to detoxify the toxicants which enter in to 
the body. In the present study, the total protein was decreased in the liver tissue of 
paracetamol intoxicated rats. Treatment with methanol extract of Glycyrrhiza glabra 
Linn. leaves restored the depleted protein level and protected the liver from 
intoxification. 
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The histopathological examination of liver provided a supporting evidence for 
the results obtained in biochemical analysis. 
                 The data obtained in the study proved that the components of Glycyrrhiza 
glabra Linn. leaf extract might act as scavengers of reactive oxygen species, and 
hence, could inhibit microsomal peroxidation, membrane destruction and enzyme 
damage. 
 
It may be possible that the natural antioxidants strengthen the endogenous 
antioxidant defense from ROS ravage and restore the optimal balance by neutralizing 
the reactive species. Natural antioxidants are gaining immense importance by virtue 
of their critical role in disease prevention. 
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CONCLUSION 
In conclusion, the results of this study demonstrate that the methanol extract of 
Glycyrrhiza glabra Linn. leaves have a potent hepatoprotective action against 
paracetamol induced hepatic damage in rats. It’s mode in affording the 
hepatoprotective activity against paracetamol induced liver damage may be due to cell 
membrane stabilization, hepatic cell regeneration and enhancement of antioxidant 
enzymes such as catalase, superoxide dismutase and glutathione peroxidase 
production. In spite of the unknown mechanism of action, the obvious 
hepatoprotective effect of Glycyrrhiza glabra Linn. leaves on paracetamol induced 
liver damage may have potential in clinical applications. The hepatoprotective and 
antioxidant potential of extract could have been brought about by various 
phytochemical principles i.e flavonoids, alkaloids, phenolics and tannins present in 
Glycyrrhiza glabra Linn. leaves.   
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